Crucial Role of Drosophila Neurexin in Proper Active Zone Apposition to Postsynaptic Densities, Synaptic Growth and Synaptic Transmission by Li, Jingjun
  
CRUCIAL ROLE OF DROSOPHILA NEUREXIN IN PROPER ACTIVE ZONE APPOSITION 
TO POSTSYNAPTIC DENSITIES, SYNAPTIC GROWTH AND SYNAPTIC TRANSMISSION 
 
 
 
 
 
JINGJUN LI 
 
 
 
 
 
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in 
partial fulfillment of the requirements for the degree of Doctor of Philosophy in the 
Curriculum of Neurobiology, School of Medicine 
 
 
 
 
 
Chapel Hill 
2007 
 
 
Approved by: 
 
Manzoor Bhat, Ph.D. 
 
Stephen Crews, Ph.D.  
 
Jay Brenman, Ph.D. 
 
Paul Manis, Ph.D. 
 
Franck Polleux, Ph.D. 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
©2007 
Jingjun Li 
All Rights Reserved 
 
 
iii 
 
 
 
 
 
ABSTRACT 
 
JINGJUN LI: Crucial Role of Drosophila Neurexin in Proper Active Zone Apposition 
to Postsynaptic Densities, Synaptic Growth and Synaptic Transmission 
(Under the direction of Manzoor Bhat) 
  
 Trans-synaptic adhesion molecules, a family of cell adhesion molecules that 
mediate the coordinated interactions between pre- and postsynaptic membrane, are 
thought to mediate target recognition, initiate synapse formation and alignment, maintain 
the integrity of synapse, and regulate synaptic function during synapse development and 
remodeling. Among these, neurexins—a family of highly conserved neuron-specific 
transmembrane proteins have been proposed to act as a key synapse organizer required 
for synapse formation and neurotransmitter release. However, their in vivo functions 
remain elusive, particularly due to the complexity and redundancy of mammalian 
neurexin genes.  
 Here, we report the cloning and characterization of the Drosophila homolog of 
neurexin genes. In contrast to the presence of 3 neurexin genes in mammals, we found 
that the Drosophila genome contains a single neurexin gene, which we named 
Drosophila neurexin (dnrx).  In situ hybridization and immunohistochemical analyses 
revealed that dnrx is expressed in neurons of central nervous system (CNS) and localized 
to CNS synaptic regions, axons and glutamatergic neuromuscular junctions (NMJs) 
during development.  At larval NMJ, DNRX is concentrated at active zones, but also 
extends into periactive zones within synaptic boutons.  
iv 
We have obtained null mutations in the single dnrx gene. Using Drosophila 
NMJs, an excellent in vivo synapse model system, we demonstrate that dnrx loss of 
function prevents the normal proliferation of synaptic boutons, while dnrx gain of 
function in neurons has the opposite effect. Synaptic vesicle and active zone component 
markers are mislocalized along dnrx mutant axons, suggesting that DNRX is required for 
the proper recruitment and localization of key synaptic components during presynaptic 
differentiation. Postsynaptically, the distribution of postsynaptic density (PSD) proteins is 
enlarged. Conspicuously, dnrx null mutants display striking defects in synaptic 
ultrastructure with the presence of detachments between pre- and postsynaptic 
membranes, abnormally long active zones, and increased number of T-bars. These 
abnormalities result in corresponding alterations in synaptic transmission with reduced 
neurotransmitter release.  Together, our results provide compelling evidence for an in 
vivo role of neurexins in the control of synapse growth, the modulation of synaptic 
architecture and adhesive interactions between pre- and postsynaptic compartments in 
vivo. 
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CHAPTER ONE 
 
INTRODUCTION 
 
2 
Synapses are specialized intercellular junctions that link neurons and their target cells 
into functional network. Synapse development and function form the basis of many 
neuronal processes, including formation and function of neural circuitry, the ability to 
learn, and to store and recall memories. Synaptic dysfunction might be responsible for 
many neurological and behavioral disorders such as Alzheimer’s disease and autism 
(Rieckhof et al., 2003; Selkoe, 2002; Zoghbi, 2003). Thus, elucidating the mechanisms 
by which synapses develop and are modified is a central question in neurobiology. Over 
the past few decades a number of factors have been identified that play major roles in 
synapse morphogenesis and synaptic plasticity. Among these, trans-synaptic cell 
adhesion molecules that mediate the coordinated interactions between pre- and 
postsynaptic membranes stand out.  
 Several families of cell adhesion molecules that interact in a homo- or 
heterophilic manner across the synaptic cleft, including (1) cadherins, (2) ephrins and 
their receptors Ephs, (3) neurexins and their ligands neuroligins, and (4) SynCAM have 
been shown to be required for the various aspects of synaptic development and function 
(Gerrow and El-Husseini, 2006a; Scheiffele, 2003; Yamagata et al., 2003). These trans-
synaptic adhesion molecules have been proposed to mediate target recognition, induce 
pre- and postsynaptic specializations and their alignment during synapse formation, 
maintain the integrity of synapses, and regulate synaptic structure and function during 
synaptic development and remodeling. Of these, neurexins and their postsynaptic binding 
partners the neuroligins are emerging as key synapse organizing molecules.  
 The recognition of neurexins as a family of central organizing molecules for both 
excitatory and inhibitory synapses is based on the following evidence. First, neurexins are 
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widely expressed in nervous system and are neuron-specific (Ushkaryov et al., 1992). 
Second, in mammals, three neurexin genes, each of which has two promoters generating 
- and -neurexins, are subject to extensive alternative splicing. Theoretically, three 
genes, two promoters and multiple alternative splicing sites could give rise to about four 
thousand of neurexins variants. Thus, neurexins were proposed as candidate molecules to 
mediate target recognition and synaptic specificity (Missler and Sudhof, 1998a). Recent 
studies on the functional significance of a small subset of neurexin splicing variants 
support this idea (Comoletti et al., 2006; Chih et al., 2006; Rowen et al., 2002; Tabuchi 
and Sudhof, 2002; Graf et al., 2006; Boucard et al., 2005). Third, extensive protein-
protein interaction studies indicate that the trans-synaptic interaction between neurexins 
and neuroligins may bridge the synaptic cleft by aligning the presynaptic 
neurotransmitter release machinery with PSD (Ichtchenko et al., 1995; Boucard et al., 
2005; Song et al., 1999; Irie et al., 1997; Hata et al., 1993; Hata et al., 1996; Biederer and 
Sudhof, 2000). Fourth, a number of studies using cell culture systems  demonstrate that 
neurexins and their ligands neuroligins can act bidirectionally to induce synapse 
formation (Scheiffele et al., 2000; Graf et al., 2004; Dean et al., 2003; Nam and Chen, 
2005; Chih et al., 2005a; Prange et al., 2004; Levinson et al., 2005; Fu et al., 2003). Fifth, 
phenotypic analyses of -neurexin triple knockout mice reveal that -neurexins are 
required for Ca
2+
-triggered neurotransmitter release (Missler et al., 2003; Zhang et al., 
2005) and postsynaptic NMDA-receptor function (Kattenstroth et al., 2004). Lastly, 
recent genetic linkage studies have reported that mutations in neurexin genes are 
associated with autism spectrum disorders (Szatmari et al., 2007).  
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Despite the expanding evidence that highlights the essential role of neurexins in 
synaptic development and function, the key question still remains— what is the exact 
function of neurexins in vivo? 
 
1.1 Neurexin genes and structure 
Neurexins were first identified as primary receptors for -latrotoxin, a component of 
black widow spider venom, which triggers massive neurotransmitter release (Ushkaryov 
et al., 1992). Mammalian genomes contain three neurexin genes. Each gene has two 
promoters. The upstream promoters generate longer transcripts encoding -neurexins, 
whereas the promoters located in an intron of -neurexins generate shorter transcripts 
encoding -neurexins. Thus, -neurexins are the truncated isoforms of -neurexins with 
a unique N-terminus, but share identical transmembrane domain and cytoplasmic 
sequences with -neurexins. The extracellular region of -neurexins is composed of 
three LamG-EGF-LamG repeats, whereas -neurexins contain a single LamG domain 
(Missler and Sudhof, 1998a) (Fig. 1.1). The extracellular sequences of neurexins share 
some homology to those in extracellular matrix proteins such as laminin and agrin, 
suggesting a possible adhesive function (Rudenko et al., 2001). The intracellular tail of 
neurexins contains a PDZ binding motif that mediates interactions with PDZ scaffolding 
proteins. The six principal transcripts of the three neurexin genes are subject to extensive 
alternative splicing, which arises from five canonical alternative splice sites in -
neurexins, and two in -neurexins (Missler and Sudhof, 1998a)(Fig. 1.1). The expression 
of neurexin splicing isoforms is regulated both temporally and spatially during 
development, and alternative splicing regulates the protein-binding properties of 
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neurexins (see The Protein Interaction Map of Neurexins). Theoretically, neurexin 
genes could generate about four thousand isoforms which differ in extracellular 
sequences (Rowen et al., 2002; Tabuchi and Sudhof, 2002), therefore, raising the 
possibility that the expression of neurexin splicing variants could encode the specificity 
of synaptic circuits. 
 
1.2 Expression and synaptic localization of neurexins 
Northern blot and in situ hybridization studies revealed that neurexins are expressed 
throughout the CNS, exclusively in postmitotic neurons (Puschel and Betz, 1995; 
Ushkaryov et al., 1992). During development, the expression of neurexins is highly 
regulated (Gorecki et al., 1999; Patzke and Ernsberger, 2000; Puschel and Betz, 1995). 
Each of the six principal neurexin isoforms (I¸ I, II, II, III and III) displays 
differential but overlapping expression pattern in various regions of brain, such that most 
neurons express multiple neurexins (Ullrich et al., 1995). Furthermore, at least a subset of 
the splicing variants are known to exhibit distinct and spatially separated distribution 
patterns at the cellular level (Ichtchenko et al., 1995). 
 The expression of neurexins including the levels and spatial patterns is also 
regulated by neuronal activity and extrinsic factors in environment (Rozic-Kotliroff and 
Zisapel, 2007). For instance, the expression of specific neurexins isoforms is unregulated 
in response to neurotrophins, BMP growth factors and ischemia (Patzke and Ernsberger, 
2000; Patzke et al., 2001; Sun et al., 2000). The dynamic and inducible expression of 
neurexins indicates neurexins might be also involved in synaptic remodeling and 
plasticity. 
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 Indirect evidence from protein-protein interaction studies and functional analyses 
of neurexins has suggested the presynaptic localization of neurexins (Graf et al., 2004; 
Missler et al., 1998; Missler et al., 2003; Scheiffele et al., 2000).  In cultured neurons, 
antibody labeling showed that neurexins are concentrated in growth cones of isolated 
axons, and colocalized with synaptic markers (Dean et al., 2003; Graf et al., 2004). The 
current neurexin-neuroligin hypothesis depends on the pre- and postsynaptic localization 
of neurexins and neuroligins, respectively. However, in vivo, the precise subcellular 
localization of neurexins remains elusive. Several recent findings have suggested that 
neurexins might reside in the postsynaptic sites as well, thus challenging the current 
trans-synaptic neurexin-neuroligin model. 
Kattenstroth et al found that NMDA-receptor function is impaired in postsynaptic 
cortical neurons of -neurexin knockout mice via a cell-autonomous mechanism, 
indicating that -neurexins might locate and function at postsynaptic sites as well 
(Kattenstroth et al., 2004). Using immunoelectron microscopy, Scheiffele and colleagues 
confirmed that endogenous neurexins are localized to axons and presynaptic terminals. 
Interestingly, they also revealed that neurexins are abundant in the PSD (Taniguchi et al., 
2007). The distribution of anti-neurexin gold particles has a peak centered at the 
presynaptic active zone and PSD, but was also observed outside of active zone and PSD 
within presynaptic terminals and spines. The neurexin antibodies used in ultrastructural 
studies are pan-neurexin antibodies, which do not allow any conclusion regarding the 
localization of specific neurexin isoforms, i.e. whether specific neurexin isoforms target 
to presynaptic, postsynaptic, or both pre- and postsynaptic sites. To address this question, 
they generated transgenic mice overexpressing one specific neurexin I isoform tagged 
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with GFP in neurons, and found a significant amount of this specific neurexin I isoform 
appeared in the postsynaptic compartments. Furthermore, they demonstrated that 
postsynaptic expression of neurexins might inhibit neuroligin function via cis-interaction 
with neuroligins on the postsynaptic membrane in vitro. However, one caveat with 
overexpression conditions is that the overexpressed protein could be mis-sorted to 
dendritic spines. Indeed, a recent study using a novel biochemistry approach which has 
been validated by electron microscopy found that neurexin I is principally presynaptic 
(Berninghausen et al., 2007).  
Additional studies are required to define the precise synaptic localization of 
neurexin isoforms, particularly whether there are neurexin isoforms exclusively 
distributed to postsynaptic sites. Nevertheless, the unexpected postsynaptic localization 
of neurexins suggests that the function and the action modes of neurexins are more 
complicated and diverse than previously thought.  
 
1.3 The protein interaction map of neurexins  
Extensive protein-protein interaction and in vitro studies have established a protein-
interaction map of neurexins (Fig. 1.2). Extracelluarly, neurexins bind to neuroligins, 
dystroglycan and neurexophilins. The interactions are selectively regulated by Ca
2+
, 
alternative splicing, and posttranslational modifications including oligomerization and 
glycosylation. Intracelluarly, neurexins interact with synaptic vesicle protein 
synaptotagmin and PDZ scaffolding proteins CASK and Mints. 
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Extracellular binding partners 
Neuroligins. Neuroligins, the most extensively studied neurexin binding partners, bind to 
both - and -neurexins in a Ca2+ -dependent manner (Ichtchenko et al., 1995; 
Ichtchenko et al., 1996).  Five neuroligin genes are expressed in human, and four in 
rodents (neuroligin 1, 2, 3, and 4) (Ichtchenko et al., 1996; Jamain et al., 2003).  Like 
neurexins, neuroligins are single transmembrane proteins that contain a large, 
alternatively spliced extracellular sequence and a PDZ binding motif at the intracellular 
tail. The major extracellular domain of neuroligins is an inactive acetylcholinesterase 
(AchE)-like domain, which mediates the binding of neurexins. Neuroligins are localized 
to postsynaptic densities (Song et al., 1999) and interact with several scaffold proteins 
such as PSD-95, thereby associated with neurotransmitter receptors, ion channels and 
signaling complexes (Hirao et al., 1998; Irie et al., 1997; Meyer et al., 2004). 
Interestingly, neuroligin 1 and neuroligin 2 is predominantly localized to excitatory and 
inhibitory synapses, respectively (Song et al., 1999; Varoqueaux et al., 2004).  
 The neurexin-neuroligin interaction is controlled by gene selection, the splicing 
codes of both neurexins and neuroligins, and oligomerization of neuroligins. For instance, 
biochemical assays showed that the binding affinity of different neuroligins (neuroligin 
1-4) and neurexin 1 varies more than two orders of magnitude in range. Neuroligin 1 
has the highest binding affinity to neurexin 1, whereas neuroligin 2 displays the lowest 
affinity (Comoletti et al., 2006). Alternative splicing in neurexins and neuroligins also 
regulates binding affinity. Recent protein interaction assays and cell culture studies 
highlight the selectivity and functional significance of splicing codes conferred by 
splicing at site B in neuroligins (one of two splicing sites of neuroligins—splicing site A 
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and B) and at site 4 in -neurexins (Boucard et al., 2005; Chih et al., 2006; Comoletti et 
al., 2006; Graf et al., 2006) . -neurexins selectively bind to neuroligins lacking an insert 
at site B (-B neuroligins), whereas -neurexins can bind to neuroligins regardless of 
splicing at site B in neuroligins. Splicing site 4 in -neurexins modulates neuroligin 
binding. -Neurexins containing an insert at site 4 interact preferentially with –B 
neuroligins, while -neurexins lacking an insert at site 4 interact with –B neuroligins and 
+B neuroligins with equal affinity (Fig. 1.3). Such splicing codes that guide interactions 
between neurexins and neuroligins have been shown to affect the selective formation of 
excitatory or inhibitory synapse in cultured cells (see Modulation of synapse 
specificity). 
 Crystal structural studies on neurexin LamG domains that mediate the interaction 
of neurexins with their binding partners provide a structural framework and suggest how 
alternative splicing and Ca
2+
 might control ligand binding (Comoletti et al., 2007; 
Sheckler et al., 2006; Rudenko et al., 1999). The studies revealed that alternative splicing 
sites are located on the so-called hyper-variable surface, which is also the protein 
interaction surface, and reshapes as a result of alternative splicing. A Ca
2+
 binding site is 
located at the center of hyper-variable surface. Moreover, alternative splicing can affect 
Ca
2+ 
binding sites. 
 Oligomerization of neuroligins is necessary for the binding of neuroligins to 
neurexins. An AchE-like domain mediates the dimerization of neuroligins, and mutations 
of residues in this domain results in loss of neuroligin 1 binding to -neurexin (Comoletti 
et al., 2003; Dean et al., 2003).  
 
10 
Dystroglycan. In addition to the extracellular matrix proteins—laminin, agrin and 
perlecan, dystroglycan, a heavily glycosylated component of dystrophin-glycoprotein 
complex, interacts with both - and -neurexins. The binding is dependent on Ca2+, 
alternative splicing of neurexins,
 
and the glycosylation of dystroglycan (Sugita et al., 
2001). Dystroglycan is expressed in muscle cells as well as a variety of cell types in the 
brain (Montanaro and Carbonetto, 2003). In cultured hippocampal neurons, it appears to 
be associated with GABAergic synapses, but not essential for GABAergic synapse 
formation (Levi et al., 2002). Brain-specific deletion of dystroglycan in mice led to brain 
malformations including defects in neuronal migration, and impaired long-term 
potentiation in hippocampal slices. It is notable that the basal synaptic transmission is not 
affected in dystroglycan deficient mice (Moore et al., 2002). Therefore, the exact 
localization and function of dystroglycan in synapses remain to be investigated. 
 
Neurexophilins. Only -neurexins, but not -neurexins, interact with neurexophilins, a 
family of small neuropeptide-like protein, in a tight complex. The interaction is not Ca
2+
-
dependent (Missler and Sudhof, 1998b; Petrenko et al., 1996). In contrast to the wide 
expression of -neurexins in CNS neurons, the expression of neurexophilins 1 and 3 (the 
only neurexophilins that bind -neurexins in mice) is  restricted to distinct brain regions 
and limited populations of neurons (Beglopoulos et al., 2005; Clarris et al., 2002; 
Petrenko et al., 1996). The brain morphology of single knockout mice is normal, but 
neurexophilin-3 deficient mice showed impaired sensory information processing and 
motor coordination, suggesting a functional role of neurexophilins in modulating selected 
neuronal circuits (Beglopoulos et al., 2005; Missler et al., 1998). 
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Intracellular binding partners 
Intracelluarly, neurexins interact with PDZ domain proteins CASK (Hata et al., 1996) 
and Mints (Biederer and Sudhof, 2000), which can interact with synaptic vesicle fusion 
protein Munc18 (Borg et al., 1999; Hata and Sudhof, 1995; Okamoto and Sudhof, 1997) 
and presynaptic voltage-gated Ca
2+
 channels (Maximov et al., 1999). Consistent with the 
biochemical association of these scaffolding proteins with neurotransmitter exocytosis 
apparatus, the rate of spontaneous neurotransmitter release events is changed in CASK 
and Mints knockout mice (Ho et al., 2006; Ho et al., 2003; Atasoy et al., 2007). The C 
termini of neurexins can also directly bind to synaptotagmins, synaptic vesicle proteins 
that regulate neurotransmitter exocytosis (Perin, 1994). Therefore, the intracellular 
interactions of neurexins suggest that neurexins might recruit or organize synaptic 
vesicles and neurotransmitter release machinery. 
 
 Taken together, the protein-interaction map of neurexins have led to the 
hypothesis that the trans-synaptic interaction of neurexins and their relevant ligands, such 
as neuroligins, might bridge the synaptic cleft aligning the presynaptic neurotransmitter 
release machinery with postsynaptic neurotransmitter receptors and signaling complexes.  
However, whether certain protein-protein interactions, such as neurexins and 
dystroglycan, neurexins and the scaffolding protein CASK, are necessary for synaptic 
development and function in vivo is still uncertain. Studies on functional relevance of 
these interactions will provide insights into the underlying molecular mechanisms by 
which neurexins function. 
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1.4 Function of neurexins at synapses 
The complexity and redundancy of neurexin genes in mammals pose a tremendous 
difficulty for understanding their function in vivo. A number of studies using cell culture 
systems have first demonstrated the functional significance of transynaptic neurexin-
neuroligin complex in both excitatory and inhibitory synapse formation in vitro. 
 
Neuroligin-neurexin trans-synaptic interaction and synaptogenesis in vitro 
Using a coculture system that consists of non-neuronal cells and neurons, Scheiffele and 
colleagues (Dean et al., 2003; Scheiffele et al., 2000) first demonstrated the following 
important findings from the neuroligin point of view: (1) neuroligins can induce the 
assembly of presynaptic terminals via neurexins, (2) clustering of neurexins is sufficient 
to induce accumulation of synaptic vesicle proteins through interactions that require the 
cytoplasmic domain of neurexins (Dean et al., 2003). From the neurexin point of view, 
Graf et al (Graf et al., 2004) revealed that neurexin can induce postsynaptic 
specializations of both glutamatergic and GABAergic synapse via neuroligins. Lateral 
aggregation of neuroligins is sufficient to initiate postsynaptic organization. They also 
found that for glutamate receptors neurexins only induce clustering of NMDA but not 
AMPA receptors. Consistent with the findings in such artificial hemi-synapses formed by 
non-neuron and neuron cells, overexpression and knockdown of neuroligins in cultured 
neurons results in an increase and decrease in synapse number, respectively. Moreover, 
electrophysiological analysis revealed that knockdown of neuroligins leads to a 
predominant reduction of inhibitory synaptic function, suggesting that neuroligins might 
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also control the functional balance of excitatory and inhibitory synapses. In summary, the 
important findings in cultured cells suggest that neurexins and neuroligins can work 
together to induce synapse formation in a bidirectional manner, i.e., neurexin and 
neuroligins promote the recruitment and assembly of synaptic vesicle proteins and 
postsynaptic scaffolding proteins and receptors, respectively, in pre- or postsynaptic sites.  
 
In vivo functions 
The complete neurexin knockout mice are not available yet. Using -neurexin triple-
knockout mice, Missler and colleagues (Missler et al., 2003; Zhang et al., 2005) 
demonstrated that extracellular domains of -neurexins are essential for Ca2+-triggered 
neurotransmitter release. Intriguingly, mice deficient in all -neurexins did not show any 
alterations in brain anatomical structure and synapse ultrastructure except for a 
significant reduction in the number of GABAergic synapses. However, synaptic 
transmission was severely impaired in triple-knockout mice due to a defect in Ca
2+
 
channel function. These important findings raise a number of questions. To name a few, 
(1) how do -neurexins couple or regulate Ca2+ channel function? Although the number 
of cell-surface Ca
2+
 channels appears normal in knockout mice, whether they are 
localized to the right place—the active zone, has not yet been examined; (2) the fact that 
-neurexin triple knockout mice died on postnatal day1 (P1) due to respiratory failure, 
early before the peak of synaptogenesis in mice (P6-P13), prevents a thorough 
assessment of the role of -neurexins in synapse development. 
 Similar to -neurexin knockout mice, mice lacking neuroligins 1-3 (neuroligin 4 
is expressed at a very low level in brain) die shortly after birth due to respiratory failure. 
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Synapses appeared to be normal in number and morphology. But glutamatergic and 
GABA-mediated neurotransmission were impaired, including a dramatic decrease in 
spontaneous GABAergic activity, a moderately reduced spontaneous glutamatergic 
activity, and a marked increase in the failure rate of evoked GABAergic transmission 
(Varoqueaux et al., 2006). Consistent with the central finding of in vitro studies, synaptic 
dysfunction in neuroligin knockout mice also leads to a shift in the excitation/inhibition 
(E/I) balance. Although the phenotype in synaptic transmission could be partly due to 
reduced postsynaptic clustering of GABA receptors and reduced levels of several 
synaptic vesicle proteins observed in neuroligin triple knockout mice, how neuroligins 
regulate synaptic function and how the neuroligin phenotype is related to neurexins are 
not clear. Particularly, whether the localization and expression level of neurexins is 
altered in neuroligin triple knockout mice is not known.  
 Together, initial knockout studies on the in vivo function of -neurexins and 
neuroligins suggest that neurexins and neuroligins are essential for synaptic transmission 
but dispensable for the initial formation of synapses (the establishment of initial contact). 
One explanation for the discrepancy regarding the essential role of neurexins and 
neuroligins in initial synapse formation between cell culture and knockout mice studies is 
that other synaptogenic adhesion molecules might compensate the loss of neuroligins or 
-neurexins in vivo. Further studies are required to assess the in vivo role of neurexins 
and neuroligins in synaptic development and function, and their functional relevance. 
This is more pressing for neurexins due to the lack of complete neurexin null mutant 
animal model. It is notable that the premature death of -neurexin and neuroligin triple 
knockout mice make it impossible to identify the in vivo role of neurexins and 
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neuroligins in late stages of synapse development, synaptic plasticity, learning and 
memory. However, generating inducible triple knockout animal model will be a daunting 
task in mammals. 
 
Modulation of synapse specificity 
Difference in the excitatory vs. inhibitory synaptic localization and/or binding affinities 
between neurexin and neuroligin isoforms might contribute to the specification of 
excitatory or inhibitory synapses. Neuroligin 1 and neuroligin 2 are differentially 
localized to excitatory and inhibitory synapses, respectively. The functional significance 
of neuroligin 1 vs. neuroligin 2 in specification of excitatory vs. inhibitory synapses has 
recently been verified (Chubykin et al., 2007). In cultured neurons, neuroligin-1 
overexpression specifically increased the number of functional excitatory synapses, 
whereas neuroligin2 specifically enhanced the number of inhibitory synapses. 
Accordingly, decreased excitatory and inhibitory synaptic responses were observed in 
neuroligin-1 and neuroligin-2 knockout mice, respectively. Moreover, alternative splicing 
regulates neurexin-neuroligin interactions, thus might selectively affect the development 
and function of excitatory and inhibitory synapses. For instance, it has been shown in 
artificial synapses that the presence of the S4 insert in neurexin 1- preferentially reduces 
glutamatergic but not GABAergic synaptogenic activity of neurexin 1- (Graf et al., 
2006). 
 Why neurexins and neuroligins appear to have a stronger role in GABAergic 
synapse development is still an open question.  One possibility is that there are more 
transynaptic cell adhesion molecules localized at glutamatergic than at GABAergic 
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synapses, which could compensate for the loss of neurexins and neuroligins (Craig and 
Kang, 2007).  
 
1.5 Neurexin-neuroligin pathway and Autism Spectrum Disorders 
Autism spectrum disorders (ASD) are a heterogeneous neurodevelopmental syndrome 
characterized by abnormal social interactions, impaired communication, and repetitive 
behavior. The concordance rate of ASD for identical twins is 90%, but less than 10% for 
fraternal twins and siblings, suggesting a strong genetic component (Geschwind and 
Levitt, 2007). Causes of ASD are not known. Among many hypotheses that have been 
postulated to cause ASD, mounting evidence supports that synapse abnormalities might 
be responsible for ASD (Zoghbi, 2003). In particular, an imbalance of E/I ratio in neural 
circuitry has been associated with autisms (Rubenstein and Merzenich, 2003; Polleux and 
Lauder, 2004). The direct evidence derives from the genetic findings that mutations in 
neurexin-neuroligin pathway are reproducibly associated with ASD.  Jamain et al first 
reported that two pairs of Swedish brothers with ASD carry mutations in neuroligin 
genes—a missense mutation in neuroligin 3 (R451C) and nonsense mutation in 
neuroligin 4 (396X) (Jamain et al., 2003). Subsequently, two independent groups also 
found that nonsense and missense mutations in neuroligin 4 are associated with ASD and 
mental retardation (Yan et al., 2005; Laumonnier et al., 2004). Recently, mutations in 
Shank3, a scaffolding protein associated with neuroligins, have been identified in ASD 
families and individuals (Durand et al., 2007). More recently, the Autism Genome Project 
Consortium, a group of over 50 institutions in North America and Europe, carried out the 
largest linkage scan and copy number variation analyses to date by using samples from 
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more than 1100 ASD families with at least two affected individuals, found neurexin I 
gene associated with ASD (Szatmari et al., 2007). These findings led to the hypothesis 
that abnormalities in neurexin-neuroligin pathway are associated with ASD (Garber, 
2007). 
 To directly test this hypothesis, Tabuchi et al introduced the R451C mutation into 
the endogenous neuroligin-3 gene in mice. The knockin mutant mice display increased 
inhibitory synaptic transmission and impaired social interactions, but enhanced abilities 
in spatial learning (Tabuchi et al., 2007). Although the behavioral abnormalities observed 
in neuroligin-3 knockin mice are only analogous to some diagnostic symptoms of ASD 
and autistics with enhanced cognitive abilities are extremely rare, neuroligin-3 knockin 
mice will be a very useful model to study ASD. The findings that R451C mutation 
resulted in an increase in inhibitory transmission without affecting excitatory 
transmission strongly support the hypothesis that a shift in E/I balance might contribute 
to the pathogenesis of ASD. Future studies on the mechanisms how abnormalities in 
neurexin-neuroligin pathway alter synapse development and function, shift the E/I 
balance in key neural circuits, and lead to autistic behavioral abnormalities will shed light 
on the pathogenesis and treatment of ASD. 
 
1.6 Drosophila larval NMJ as an excellent in vivo model system to study synapse 
development and function 
Drosophila body wall musculature has segmentally repeated pattern (Hoang and Chiba, 
2001). In each embryonic/larval abdominal hemi-segment, there are 30 skeletal muscles 
innervated by about 40 motor neurons located within the ventral nerve cord. Each of the 
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30 muscle fibers can be easily identified by its position, orientation and shape. The 
innervating motor axons branch onto muscle surface forming a series of varicosities, 
called synaptic boutons. Based on their morphology, these boutons can be divided into 
three main types. Type-I boutons, the major class of terminals that innervate all body wall 
muscles, are glutamatergic. Type-II or type-III terminals innervate subsets of muscles and 
contain octopamine or peptide neurotransmitters as well as glutamate. At each 
developmental stage, type-I NMJs display a highly stereotypic morphology, including 
axon innervating and branching pattern, bouton number and size on each individual 
muscle.  
 Ultrastructurally, the morphology of Drosophila type I NMJs more resembles 
vertebrate central synapses than vertebrate NMJs. In contrast to vertebrate NMJs that 
show a 50- to 60-nm wide synapse cleft between the membranes of motor neuron and 
muscle and contain a basal lamina, the synapse cleft in Drosophila NMJs does not 
contain an evident basal lamina and is only 15- to 20-nm wide (Prokop and 
Meinertzhagen, 2006). At vertebrate NMJs, active zones and PSDs are not exactly 
aligned across the synapse cleft: PSDs are present mostly on the crests of junctional 
folds, and presynaptic active zones are located across the openings of junctional folds 
instead of the crests of junctional folds (Hughes et al., 2006). At Drosophila NMJ, 
however, PSDs are exactly juxtaposed to active zones. The active zone at Drosophila 
NMJs is characterized by so-called T-bars, due to their T-shaped appearance in cross 
sections of electron micrographs.  The three-dimensional structure of T-bar resembles a 
pedestal table comprising a base surmounted by a platform. Clouds of synaptic vesicles 
surround the T-bar. Some vesicles appear physically attached to the T-bar, and some 
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fused to the presynaptic plasma membrane beneath the T-bar. The T-bar is thought to 
bridge synaptic vesicles in close proximity to release sites to facilitate neurotransmitter 
release (Prokop and Meinertzhagen, 2006). Functionally, the T-bar is analogous to the 
grid- or mesh-like dense structure formed by the cytomatrix at the active zone (CAZ) of 
vertebrate synapses (Dresbach et al., 2001).  
 Bruchpilot (BRP), as the first component of T-bars, has been recently identified. 
It is a homologue of mammalian CAZ component protein CAST, which binds RIM in a 
complex with Bassoon and Munc-13. brp mutants show reduced evoked vesicle release, 
altered short-term plasticity, but normal spontaneous transmission. At brp mutant active 
zones, T-bars are entirely lost and calcium channel densities are reduced. Thus, BRP is 
proposed to establish the proximity between Ca
2+ 
channels and vesicles to allow efficient 
transmitter release (Kittel et al., 2006; Wagh et al., 2006).  
 Synapse formation at the NMJ starts during the late stages of embryogenesis. 
Motor neuron growth cones establish the initial contacts with specific muscle fibers, 
forming enlarged varicosities—synaptic boutons, containing the first active zones and 
postsynaptic densities (Featherstone and Broadie, 2000). The embryonic NMJs have only 
a few branches and boutons. However, during larval development, NMJs grow 
substantially in size and strength to match the continuous increase in muscle size, to 
maintain appropriate synaptic efficacy, and to achieve proper muscle depolarization 
(Griffith and Budnik, 2006). The NMJ expansion involves the formation of new boutons 
and an increase in the number of active zones per bouton(Schuster et al., 1996; Zito et al., 
1999). This coordinated development of pre- and postsynaptic specializations during 
synaptic growth is a good example of synaptic homeostasis. A number of genes have 
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been identified to control synaptic growth, including the cell adhesion molecule Fasciclin 
II (Schuster et al., 1996), the microtubule-associated protein Futsch (Roos et al., 2000), 
the cytoskeleton adaptor protein Nervous Wreck (Coyle et al., 2004), the ubiquitin ligase 
Highwire (Wan et al., 2000), the deubiquitinating protease Fat Facets (DiAntonio et al., 
2001), and the components in BMP retrograde signaling pathways such as BMP type II 
receptor Wishful thinking. 
  In addition to highly-stereotyped morphology, well-studied ultrastructure and 
development, Drosophila larval NMJs offer a number of exceptional advantages as an 
excellent in vivo model system to study synapse development and function (Koh et al., 
2000; Featherstone and Broadie, 2000): (1) The powerful Drosophila genetics has 
provided a variety of genetic tools and techniques to tackle the fundamental questions on 
synapse development and function, and to genetically dissect underlying mechanisms. 
Forward genetic screens have facilitated the discovery of new players in synapse 
development and function. (2) Type-I NMJs have many molecular features in common 
with central synapses in the mammalian brain. Many key synaptic molecules have shown 
striking conversation in regard to their functions and underlying mechanisms, but less 
gene redundancy in Drosophila. (3) Because of their large size, larval NMJs are easily 
accessible for a variety of cell biology techniques including electron microscopy and in 
vivo live imaging, and electrophysiological recordings. 
 
1.7 Research Goals 
Despite the expanding evidence suggesting that neurexins may act as a key player in 
synapse development and function, the exact in vivo function of neurexins still remains 
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exclusive, particularly due to the complexity and redundancy of neurexin genes in 
mammals. A potential strategy to tackle this longstanding question is to use a simpler 
model system, such as the fruit fly. We identified a single Drosophila neurexin gene 
(dnrx) that has striking conservation with mammalian neurexins. To understand the in 
vivo function of DNRX, I have accomplished the following specific aims: (1) 
characterize the dnrx gene and determine the precise subcellular localization of DNRX at 
larval NMJ; (2) generate dnrx loss-of-function mutants; and (3) identify the role of 
DNRX in synaptic development and function using Drosophila larval NMJ as a model 
system.   
 I present data demonstrating that DNRX is concentrated at the active zone of 
presynaptic terminals at glutamatergic NMJs. Phenotypic analyses of dnrx null mutants 
revealed that DNRX plays a crucial role in the control of synapse growth, the modulation 
of synaptic architecture and the regulation of synaptic transmission. The described studies 
provide novel insights into understanding the function of neurexins in vivo, and offer a 
strong basis for the interpretation of observations at mammalian central synapses.  
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Figure 1.1 Structure and Alternative Splicing of Neurexins 
-neurexins are composed of a large extracellular region containing a signal peptide (SP) 
and three LamG-EGF-LamG repeats, a single transmembrane region (TMR), and a short 
cytoplasmic region containing a PDZ binding motif. -neurexins contain only one LamG 
domain, which is preceded by a N-terminal sequence specific for -neurexins (N). 
Alternative splicing sites (SS) are numbered and indicated by arrows. There are five 
alternative splicing sites present in -neurexins, and two present in-neurexins. 
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Figure 1.2 The Protein Interaction Map of Neurexins 
The extracellular region of neurexins binds to neuroligins and dystroglycan in a Ca
2+
-
dependent manner. Neuroligins are localized to PSDs and associated with 
neurotransmitter receptors by interactions with scaffolding proteins such as PSD-95. 
Dystroglycan is an integral component of the dystrophin-associated glycoprotein 
complex. The glycosylation of dystroglycan is required for dystroglycan to bind to 
neurexins. Intracelluarly, neurexins interact with synaptic vesicle protein synaptotagmin 
and PDZ domain proteins Mints and CASK.  Mints and CASK are linked to synaptic 
vesicle exocytosis machinery including presynaptic Ca
2+ 
channels and Munc-18. 
Neurexophilins, a family of small neuropeptide-like protein, also directly bind to 
neurexins in a high affinity. 
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Figure 1.3 Neurexin-neuroligin Splicing Codes and Selective Interactions 
(A) Potential splicing sites in neurexins and neuroligins. Arrows indicate the alternative 
splicing sites in - and -neurexins (NRX), neuroligin (NLG) 1 and 2. 
(B) Splicing codes that guide the selective interactions of neurexins and neuroligins. -
neurexins selectively bind to neuroligins lacking an insert at SSB (-B neuroligins), 
whereas -neurexins can bind to neuroligins regardless of splicing at SSB in neuroligins. 
-Neurexins containing an insert at SS4 interact preferentially with –B neuroligins, while 
-neurexins lacking an insert at SS4 interact with –B neuroligins and +B neuroligins with 
equal affinity. 
  
  
 
 
CHAPTER TWO 
DROSOPHILA NEUREXIN IS EXPRESSED IN CENTRAL NEURONS AND 
CONCENTRATED AT ACTIVE ZONES 
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2.1 Abstract 
 
Neurexins, a family of highly conserved neuron-specific transmembrane proteins, have 
been proposed to act as a key synapse organizer required for synapse formation and 
neurotransmitter release. However, their in vivo functions remain elusive, particularly due 
to the complexity and redundancy of mammalian neurexin genes. Here, we report the 
cloning and characterization of the Drosophila homolog of neurexin genes. In contract to 
the presence of 3 neurexin genes in mammals, we identified a single neurexin gene in the 
Drosophila genome, which we named Drosophila neurexin (dnrx). Toward a better 
understanding of DNRX function, we examined the expression and subcellular 
localization of DNRX during development. In situ hybridization reveals that dnrx 
expression starts before the differentiation of presynaptic terminals, and is highly 
enriched in the neurons of central nervous system. Consistent with this, 
immunocytochemical staining shows that DNRX localizes to CNS synaptic regions, 
axons, and glutamatergic neuromuscular junctions (NMJs) during development.  At larval 
NMJ, DNRX is concentrated at active zones, but also extends into periactive zones 
within synaptic boutons. These findings indicate the potential roles of DNRX in synapse 
development and function, particularly the assembly and organization of active zone, 
synaptic transmission, and/or synaptic growth.  
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2.2 Introduction 
 
Synapses are specialized cell-cell connections that link neurons and their target cells into 
functional network through neurotransmission.  Neurotransmission depends on two 
ultrastructurally defined synapse components— the presynaptic active zone and 
postsynaptic density (PSD). The active zone, which is defined as the presynaptic region 
specialized for the release of neurotransmitter-filled vesicles, is juxtaposed against the 
PSD, which contains neurotransmitter receptors and signaling complexes to respond to 
neurotransmitters (Waites et al., 2005). Recent evidence has highlighted the importance 
of trans-synaptic cell adhesion molecules in synapse development and function (Dalva et 
al., 2007; Gerrow and El-Husseini, 2006b; Scheiffele, 2003; Yamagata et al., 2003). Of 
these, neurexins—a family of highly conserved neuron-specific transmembrane proteins, 
have been proposed to act as a key synapse organizer required for synapse formation and 
neurotransmitter release (Dean and Dresbach, 2006; Craig and Kang, 2007). 
 Mammalian genomes contain three neurexin genes, each of which has two 
promoters generating - and -neurexins. The extracellular region of -neurexins is 
composed of three LamG-EGF-LamG repeats, whereas -neurexins contain a single 
LamG domain (Missler and Sudhof, 1998a) and a unique N-terminus. -neurexins and -
neurexins share identical transmembrane domain and cytoplasmic sequences. Neurexins 
are subject to extensive alternative splicing, generating a large number of variants 
(Missler and Sudhof, 1998a; Rowen et al., 2002; Tabuchi and Sudhof, 2002), which may 
mediate synaptic specificity. (Comoletti et al., 2006; Chih et al., 2006; Rowen et al., 
2002; Tabuchi and Sudhof, 2002; Graf et al., 2006; Boucard et al., 2005). The 
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extracellular region of neurexins binds to neuroligins (Ichtchenko et al., 1995; Boucard et 
al., 2005) and dystroglycan (Sugita et al., 2001). Neuroligins are localized to PSDs (Song 
et al., 1999) and associated with neurotransmitter receptors by interaction with 
scaffolding proteins (Irie et al., 1997; Meyer et al., 2004; Hirao et al., 1998; Irie et al., 
1997). Intracelluarly, neurexins interact with the synaptic vesicle protein synaptotagmin 
(Hata et al., 1993), and PDZ domain proteins CASK (Hata et al., 1996) and Mints 
(Biederer and Sudhof, 2000), which are linked to the synaptic vesicle exocytosis 
machinery (Atasoy et al., 2007; Ho et al., 2003). Thus, the trans-synaptic interaction 
between neurexin and neuroligin may bridge the synaptic cleft aligning the presynaptic 
neurotransmitter release machinery with PSDs.  
 Important findings from cell culture studies suggest that neurexins and neuroligins 
could act bidirectionally to induce pre- and postsynaptic assembly, thus controlling 
synapse formation (Scheiffele et al., 2000; Graf et al., 2004; Dean et al., 2003; Nam and 
Chen, 2005; Chih et al., 2005; Prange et al., 2004; Levinson et al., 2005; Fu et al., 2003). 
Interestingly, phenotypic analyses of -neurexins triple knockout mice demonstrate that 
-neurexins are required for Ca2+ channel function and thus neurotransmitter release but 
are dispensable for  synapse formation (Missler et al., 2003; Zhang et al., 2005). 
Recently, a large scale genetic linkage scan and copy number variation study found 
neurexin I gene associated with autism (Szatmari et al., 2007). However, despite the 
expanding evidence indicating that neurexins may play a key role in synaptic 
development and synaptic transmission, the in vivo function of neurexins still remain 
exclusive, particularly due to the complexity and redundancy of neurexin genes in 
mammals. 
29 
 A potential strategy to resolve these issues is to use a simpler model system, such 
as the fruit fly, to investigate the in vivo function of neurexins. However, the first 
neurexin-related gene isolated in Drosophila, neurexin IV (nrx IV), is primarily expressed 
in epithelial and glial cells, where it is required for the organization and function of 
septate junctions (Baumgartner et al., 1996; Banerjee et al., 2006; Faivre-Sarrailh et al., 
2004). Nrx IV has an identical domain structure to Contactin-associated protein 1 
(Caspr1), a member of the Caspr family which is distantly related to the neurexin family 
and mediates neuron-glia interactions (Bellen et al., 1998; Bhat et al., 2001; Peles et al., 
1997; Poliak et al., 1999).   
 Taking advantage of the near completion of the Drosophila genome project 
(Adams et al., 2000), we identified a single gene with striking conservation with 
mammalian neurexins, resurrecting the initial idea of using the Drosophila system to 
understand neurexin function at synapses. In the goal of understanding the in vivo 
function of Drosophila neurexin (dnrx), we have examined the expression and the 
subcellular localization of DNRX during development. dnrx expression starts before the 
differentiation of presynaptic terminals, and is highly enriched in central neurons. DNRX 
localizes to synaptic regions, including glutamatergic neuromuscular junctions (NMJs), 
where DNRX is concentrated at the active zone within synaptic boutons. Our results 
indicate a potential role of DNRX in the formation and development of active zone, 
synaptic transmission, and/or synaptic growth. In addition, anti-DNRX antibody would 
be of general use as an active zone marker to study synapse development and function. 
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2.3 Materials and Methods 
Drosophila Strains 
Flies were raised at 25 C on standard medium. All flies used in this work are the wild-
type strain Canton-S. 
 
Cloning and Sequencing of dnrx Full Length cDNA 
A radio-labeled dnrx EST (LP03809) was used to screen a Drosophila 0-20hr embryo 
cDNA library. Overlapping partial cDNA clones were isolated, sequenced and compiled 
as a cDNA sequence of 5738 base pairs (GenBank accession number EF460788), which 
comprises an open reading frame of 5520 base pair with 5’ and 3’ UTR.  
 
Bioinformatics  
Rat neurexin 1 cDNA sequence was used to perform BLAST search against the 
Drosophila genome and EST databases, and dnrx (CG7050) was identified with the 
highest degree of similarity. The domain organization of DNRX was analyzed using 
SMART (Schultz et al., 1998). Megs 3.1 (Kumar et al., 2004) was used for sequence 
alignment (ClustalW) and phylogenetic analysis (neighbor-joining method).    
 
In situ Hybridization 
A HindIII-SalI fragment of dnrx cDNA clone encoding the 2
nd
 LamG-EGF-LamG-
domain repeat, and a PstI-NotI fragment encoding the last-LamG-domain-cytoplasmic-
region were cloned into pBluescript vector. The two resulting clones were linearized. 
Antisense and sense RNA probes were synthesized by using T7 and T3 RNA 
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polymerases, labeled with digoxigenin-UTP (Roche), and used for in situ hybridization 
following standard protocols (Kearney et al., 2004). 
 
Protein Expression and Purification of DNRX Antibody  
A cDNA fragment encoding the cytoplasmic region of DNRX was cloned into pET-28a 
and pGEX vector, respectively. His-tagged DNRX fusion protein was expressed in E.coli 
BL21(DE3) and purified using Ni-NTA agarose affinity resin (Novagen). Guinea pigs 
were immunized with this protein at Cocalico Biologicals, PA. Recombinant glutathione 
S-transferase (GST) fusion protein GST-DNRX was expressed in E.coli BL21, purified 
with glutathione-sepharose (GE Phamacia), and coupled to a NHS-activated Sepharose 
column (GE Phamacia). Antisera were affinity purified using this column. The column 
was washed in 500mM NaCl, 20mM Tris-HCl, pH 7.5, and eluted with 500mM NaCl, 
100mM glycine-HCl, pH2.7. To minimize denaturation of the antibody at low pH, the 
eluted fractions were immediately mixed with the neutralization buffer (1M Tris-HCl, 
pH8, and 10 mg/ml BSA). 
 
Immunohistochemistry and Confocal Microscopy 
Preparation and antibody staining for whole-mount embryos and dissected wandering 3
rd
 
instar larvae were performed as described by Bellen and Budnik (2000). Dissected larval 
NMJs were fixed in Bouin’s fixative (15:5:1 mixture of saturated picric acid, 37% 
formaldehyde and glacial acetic acid) for 15 min. The following antibodies were used: 
guinea pig anti-DNRX (1:500), rabbit anti-DPAK (1:2000, N. Harden, Simon Fraser 
University, Canada; (Harden et al., 1996), rabbit anti-NWK (1:2000, B. Ganetzky, 
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University of Wisconsin, Madison; (Coyle et al., 2004), monoclonal anti-discs-large 
(1:500), anti-BRP (1:500), and anti-FASII (1:100) from Developmental Studies 
Hybridoma Bank, University of Iowa. Secondary antibodies conjugated to Alexa 488 and 
568 (Invitrogen-Molecular Probes) were used at 1:400. Fluorescence conjugated anti-
HRP (Jackson Immuno Labs) antibodies were used at 1:50.  
 DNRX signal at the NMJ was detected by using the VECTASTAIN ABC system 
(Vector Laboratories) and Tyramide Signal Amplification (TSA, Invitrogen-Molecular 
Probes). Double-staining of NMJ with anti-DNRX and a second primary antibody was 
performed as following. Briefly, fixed larvae were washed in PBT (PBS containing 0.3% 
Triton X-100) and blocked for 1hr with 1% blocking reagent (TSA kit, Invitrogen-
Molecular Probes). Blocked samples were incubated with anti-DNRX and a second 
primary antibody overnight at 4 C. After washes with PBT, the samples were incubated 
with biotinylated goat anti-guinea pig antibody (1:400, Vector Laboratories) and a 
fluorescent secondary antibody. The incubation was followed by washes with PBT and 
one-hour incubation in ABC reagent (1:250 in 2% BSA /PBT, diluted 30 min before use, 
Vector laboratories). Six subsequent washes with PBT and one with PBS were followed 
by Tyramide labeling according to the manufacturer’s instructions. 
Confocal images were acquired using a Bio-Rad Radiance 2000 confocal microscope 
with LaserSharp2000 software.  
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2.4 Results 
 
DNRX is the Single Drosophila Homolog of Vertebrate Neurexins  
To identify a neurexin homolog in Drosophila, the rat neurexin 1 cDNA sequence 
(Ushkaryov et al., 1992) was blasted against the Drosophila genomic and EST databases.  
We identified an EST (LP03809) with significant homology to the C-terminal sequences 
of vertebrate neurexins.  This EST was subsequently used to screen a 0-20 hr old 
embryonic cDNA library to obtain a full-length dnrx cDNA (Gen Bank accession number 
EF460788). In contrast to the presence of three neurexin genes in mammals, our genome-
wide search revealed only a single neurexin gene (CG7050) in Drosophila (also reported 
by Tabuchi and Sudhof, 2002; Zeng et al., 2007), which we named Drosophila neurexin 
(dnrx). The DNRX protein has an identical domain structural organization to mammalian 
-neurexins (Fig. 2.1A). The large extracellular region consists of an N-terminal signal 
peptide and three LamG-EGF-LamG repeats. Although the cytoplasmic region of DNRX 
is longer than the mammalian counterparts, the PDZ binding motif at the C-terminus is 
highly conserved (Fig. 2.1C). Overall, DNRX is 36-37% identical to human -neurexins, 
and shares high amino acid sequence identity with mammalian neurexins within each 
individual protein domain (Fig. 2.1A).  
Previously, the Drosophila gene neurexin IV (nrx IV) was identified and proposed 
to belong to the neurexin family (Baumgartner et al., 1996). However, the domain 
arrangement of NRX IV differs from that of classical neurexins (Fig. 2.1A). Furthermore, 
our phylogenetic analysis shows that DNRX is the closest homolog of vertebrate 
neurexins, whereas NRX IV is only distantly related to neurexins (Fig. 2.1B). 
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dnrx Is Highly Expressed in Central Neurons 
To determine where DNRX function might be required during development, we 
performed in situ hybridization to examine dnrx expression during embryonic stages. In 
situ hybridization in embryos using two independent RNA probes revealed that dnrx 
expression was enriched in the neurons of the brain and ventral nerve cord (Fig. 2.2A, 
2.2B, and2.2C), but undetectable in muscle cells (Fig.2.2D). dnrx mRNA first appeared 
in subsets of central neurons at late stage 14 (Fig.2.2A), when axon pathfinding is nearly 
complete and  the differentiation of presynaptic terminals is about to begin (Featherstone 
and Broadie, 2000). This expression reached its highest levels at stages 16 and 17, when a 
larger number of neurons in the brain and ventral nerve cord expressed dnrx at elevated 
levels (Fig. 2.2B and 2.2C). Low levels of dnrx expression could also be detected in 
small subsets of peripheral nervous system (PNS) neurons (Fig. 2.2A). 
 
DNRX localizes to Axons, Central Synaptic Regions and Glutamatergic NMJs 
The subcellular localization of DNRX was determined by immunocytochemical analysis 
using an affinity-purified polyclonal antibody generated against the cytoplasmic region of 
DNRX. In embryos DNRX was concentrated in neuropil regions of the brain and ventral 
nerve cord, axon tracts of the ventral nerve cord, and motor axons (Fig. 2.3A and 2.3B). 
The immunoreactivity was absent in homozygous embryos of Df(3R)5C1 which uncovers 
the dnrx gene, demonstrating the specificity of the DNRX antibody (Fig. 2.3C). A similar 
DNRX distribution was observed in 3
rd
 instar larvae. DNRX is expressed in the ventral 
ganglion and subsets of neurons in brain lobes, and labels synaptic regions and motor 
axons (Fig. 2.3D).  In addition, DNRX was present at the glutamatergic type I boutons of 
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the larval body wall muscles. This was confirmed by double staining with an antibody 
against the scaffolding protein Discs-large (DLG) (Fig. 2.3E-2.3E”), which labels type I 
boutons, but not other bouton types (Fig. 2.3E’; (Lahey et al., 1994).  
 
DNRX Is Concentrated at Active Zones within Synaptic Boutons 
Confocal microscopy analysis revealed that within synaptic boutons DNRX 
immunoreactivity did not have a uniform distribution, but displayed discontinuous 
patches (Fig. 2.4A-A”, 2.4B-B”, 2.4C and 2.4D). To define the precise subcellular 
localization of DNRX in these patches, we used a number of synaptic markers. A 
presynaptic marker, Bruchpilot (BRP; (Wagh et al., 2006; Kittel et al., 2006), is thought 
to label at least one component of the active zone, the T-bar. Bright DNRX patches were 
juxtaposed and slightly overlapped with almost every BRP spot, as revealed by 
examining the labels in thin consecutive confocal slices (Fig. 2.4A-A”, arrows and 
insets). In addition, DNRX appeared to surround BRP immunoreactivity. Notably, the 
postsynaptic density marker Drosophila p-21 activated kinase (DPAK; (Sone et al., 
2000), also appeared juxtaposed to DNRX patches, but in contrast to BRP, minimal 
overlap between the labels was observed (Fig. 2.4B-B”, arrows and insets).  
We next double labeled NMJ preparation with DNRX and the so-called periactive 
zone markers, such as the cell adhesion molecule fasciclin II (FASII) (Sone et al., 2000) 
and the SH3 adaptor protein nervous wreck (NWK) (Coyle et al., 2004). In addition to 
FASII and NWK, many synaptic proteins that regulate synaptic bouton growth including 
the ubiquitin ligase highwire (Wan et al., 2000), the guanine-nucleotide exchange factor 
still life (Sone et al., 2000), and the scaffolding protein for synaptic vesicle endocytic 
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machinery  Dap 160 (Marie et al., 2004; Koh et al., 2004), are also localized to this 
region. In general, DNRX showed no overlap with NWK, although occasionally 
colocalization between less intense DNRX regions and NWK was observed (Fig. 2.4C-
C”). In the case of FASII, there are significant regions of nonoverlap with some regions 
displaying partial overlap (Fig. 2.4D-D”). Thus, within synaptic boutons DNRX appears 
to be concentrated at active zones, but also extends into periactive zones. The abundance 
of DNRX at active zones suggests its potential role in the assembly and organization of 
active zone and neurotransmission, while the extended distribution into the peri-active 
zone suggests additional function during synapse development such as synaptic growth. 
 
2.5 Discussion 
 
Trans-synaptic cell adhesion molecules mediate the coordinated interaction between pre- 
and postsynaptic membrane, affect the development and function of synapses at multiple 
levels. Among these, neurexins and neuroligin are perhaps the most extensively studied, 
and are emerging as central synaptic organizing molecules during synapse development 
and in synaptic transmission. However, their in vivo function and functional relevance 
are still unclear. The complexity and redundancy of neurexin genes in mammals have 
posed a tremendous difficulty in understanding their function in vivo. In this study, we 
have identified a single neurexin gene in Drosophila (dnrx), and characterized the 
expression pattern of DNRX during development, and defined its precise synaptic 
localization, thus providing a strong basis for the interpretation and a better 
understanding of DNRX function in vivo. 
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 In contrast to three neurexin genes in mammals, we found that dnrx is the only 
neurexin gene in Drosophila. The DNRX protein has an identical domain structure to 
vertebrate -neurexin. We have not been able to identify -neurexin or additional 
isoforms from the cDNAs we isolated and available EST sequences. Moreover, our 
Western blotting analysis with the affinity-purified antibody against the cytoplasmic 
region of DNRX revealed a single ~200 kDa band (data not shown), suggesting that no -
neurexin is present in Drosophila (also reported by Zeng et al., 2007). Although we could 
not rule out the alternative splicing isoforms with a similar molecular weight, and/or the 
soluble isoforms that is unable to be detected by our DNRX antibody; all available cDNA 
and EST sequences so far have not showed any splicing isoform. Therefore, it appears 
unlikely that dnrx is subject to extensive alternative splicing. The single neurexin gene 
and lack of polymorphism in Drosophila would offer a great advantage for genetic 
dissecting of neurexin function in vivo, and simplify the interpretation of the results. 
 Mammalian neurexins are expressed throughout the CNS and exclusively in 
neurons (Ushkaryov et al., 1992; Ullrich et al., 1995; Puschel and Betz, 1995). In cultured 
neurons, neurexins are concentrated in growth cones of isolated axons, and colocalized 
with synaptic markers (Dean et al., 2003; Graf et al., 2004). Using immunoelectron 
microscopy, Scheiffele and colleagues have recently confirmed the synaptic localization 
of neurexins, which have long been postulated by protein interaction studies.  
Unexpectedly, in addition to the presynaptic active zone, neurexins are abundant in the 
PSD as well (Taniguchi et al., 2007). The distribution of anti-neurexin gold particles has 
a peak centered at the active zone and PSD, but was also observed outside of active zone 
and PSD. It is notable that the neurexin antibodies used in this study are pan-neurexin 
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antibodies, which do not allow any conclusion regarding the localization of specific 
neurexin isoforms. That is, whether specific neurexin isoforms target to presynaptic, 
postsynaptic or both pre- and postsynaptic sites are unclear.  
 Our study shows that DNRX is widely expressed in central neurons, localized to 
synaptic regions in CNS, and concentrated at the active zone at NMJs. The expression 
pattern and the synaptic localization of DNRX show remarkable parallels with 
mammalian neurexins. Moreover, we found that the proteins that have been shown to 
interact with mammalian neurexins also have homologs in Drosophila. Therefore, we 
propose that the function of neurexins and underlying signaling mechanism are 
evolutionarily conserved. The active zone localization of DNRX indicates its potential 
role in the assembly and organization of the active zone, and/or synaptic transmission. 
Moreover, no detectable expression in muscles and minimal overlap with the PSD marker 
DPAK suggest that DNRX might primarily function at the presynaptic site at NMJ.
 The periactive zone is referred as the synaptic region that is immediately adjacent 
to active zone (Sone et al., 2000). In addition to the endocytosis machinery, cell adhesion 
molecules such as N-cadherins and signaling molecules that necessary for synapse 
development, maintenance, and plasticity also reside in the periactive zone (Sudhof, 
2004; Dustin and Colman, 2002; Sone et al., 2000; Tai et al., 2007). However, little is 
known about the organization and coordinated functions of the periactive zone. 
Interestingly, a few molecules that have been shown to regulate synaptic bouton growth 
localize to this region, including the cell adhesion molecules FASII(Sone et al., 2000), 
the cytoskeleton adapter protein NWK (Coyle et al., 2004), the ubiquitin ligase highwire 
(Wan et al., 2000), and the scaffolding protein for synaptic vesicle endocytic machinery  
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Dap 160 (Marie et al., 2004; Koh et al., 2004). Thus, it is hypothesized that the periactive 
zone is specialized for synaptic growth regulation (Coyle et al., 2004). The extended 
distribution of DNRX into this region indicates its potential role in synaptic growth.  
 In summary, our results demonstrated that dnrx, the single Drosophila neurexin 
gene, is expressed in central neurons and concentrated at the active zones within synaptic 
boutons at NMJ. The similar expression pattern and synaptic localization of neurexins in 
Drosophila and mammals, and the existence of highly conserved neurexin-interacting 
protein homolog in Drosophila suggest that the function of neurexins and underlying 
mechanism might be evolutionarily conserved. Our functional study of DNRX using 
larval NMJ in vivo model synapse system would provide insights into many aspects of 
DNRX function in synapse development and function. 
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Figure 2.1 Molecular Analysis of DNRX  
(A) Domain structure of DNRX, neurexin I, neurexin IV and Caspr1. The percent 
amino acid identity between DNRX and human neurexin I in specific domains is 
indicated. SP, signal peptide; LamG, laminin G domain; EGF, EGF repeat; DISC, 
discoidin-like domain; FIB, a region similar to fibrinogen; PGY, PGY repeat; TMR, 
transmembrane region. Dm, Drosophila melanogaster; Hs, Homo sapiens; Ce, C. elegans. 
(B) Phylogenetic analysis of human, Drosophila, and C. elegans neurexins, Drosophila 
neurexin IV and human Caspr proteins using the neighbor-joining method (Mega 3.1; 
Kumar et al., 2004). DNRX and NRXIV belong to neurexin and Caspr subfamily, 
respectively. Numbers along each branch are the bootstrap confidence value. 
(C) Multiple sequence alignment (ClustalW) of cytoplasmic sequences of Drosophila, C. 
elegans and human neurexins. The PDZ binding motif at the C-termini of neurexins is 
boxed. 
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Figure 2.2 Developmental and Cellular Distribution of dnrx Expression Revealed by 
In situ Hybridization to 0-22-hour Embryos 
(A and B) Lateral view of whole-mount embryos at late stage 14 (A) and stage 17 (B), 
showing that dnrx is abundantly expressed throughout the brain (Br) and ventral nerve 
cord (VNC). Low levels of dnrx expression were also detected in small subsets of 
peripheral nervous system neurons ([A], white arrows). 
 (C) Ventral view of a stage-17 whole-mount embryo showing dnrx mRNA distribution 
in CNS neurons. 
(D) Higher magnification of a dissected embryo showing that dnrx mRNA is enriched in 
central neurons, but undetectable in muscle cells (black arrows). 
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Figure 2.3 DNRX Localizes to Axons, CNS Neuropil Regions, and Glutamatergic 
NMJs 
(A and B) Lateral and ventral view of wild-type embryos stained with anti-DNRX 
antibody, showing that DNRX is localized in the CNS neuropil and axonal tracts 
(arrows), and motor axons ([B], arrowheads). 
(C) A Df(3R)5C1 homozygous embryo stained with anti-DNRX, showing the specificity 
of antibody. 
(D) 3
rd
 instar larval CNS stained with anti-DNRX, showing that DNRX is concentrated in 
the synaptic regions of brain lobes and ventral ganglia.  
(E-E’’) Double-staining of wide-type 3rd instar larval NMJ 6/7 with anti-DNRX (green) 
and anti-DLG (red), which labels glutamatergic type I boutons. The merged DNRX and 
DLG images show that DNRX is located at type I boutons. 
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Figure 2.4 DNRX Is Concentrated at Active Zones within Synaptic Boutons 
 (A-A”) Three consecutive single confocal slices from NMJs labeled with anti-DNRX 
and anti-BRP which labels a component of active zone, showing that bright DNRX spots 
are juxtaposed and slightly colocalized with BRP spots (Given that DNRX spots were 
associated to one side of BRP spots, such juxtaposition could not be seen in every slice, 
but could be verified in a sequence of single slices). 
(B-B”) Three consecutive single confocal slices from NMJs labeled with anti-DNRX and 
anti-DPAK which labels the PSDs, showing that DPAK and DNRX largely do not 
colocalize, and DPAK appears juxtaposed to DNRX patches.  
Columns to the right side of A-B” are high magnification views of BRP-DNRX or 
DPAK-DNRX spots indicated in the low magnification panels by arrows.  
(C-C’’) Single confocal scan of synaptic boutons double-stained for DNRX and NWK, 
which localizes to the periactive zone of presynaptic terminals, shows that DNRX and 
NWK localize to distinct areas and do not display any significant overlap.  
(D-D’’) Single confocal scan of synaptic boutons double-stained for DNRX and FASII, a 
cell-adhesion molecule defines the periactive zone of pre- and postsynaptic membrane 
shows that most of DNRX staining regions do not overlap with that of FAS II. Scale bar, 
5 µm (D”). 
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CHAPTER THREE 
 
CRUCIAL ROLE OF DROSOPHILA NEUREXIN IN PROPER ACTIVE ZONE 
APPOSITION TO POSTSYNAPTIC DENSITIES, SYNAPTIC GROWTH AND SYNAPTIC 
TRANSMISSION 
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3.1 Abstract 
 
Neurexins, a family of synaptic adhesion molecules, have been proposed to function as a 
major mediator of the coordinated pre- and postsynaptic apposition. However, key 
evidence for this role in vivo has been lacking, particularly due to the complexity and 
redundancy of mammalian neurexin genes. Here, we have obtained null mutations in the 
single Drosophila neurexin gene (dnrx). Using Drosophila larval neuromuscular 
junctions (NMJs), we demonstrate that dnrx loss of function prevents the normal 
proliferation of synaptic boutons at glutamatergic NMJs, while dnrx gain of function in 
neurons has the opposite effect. Conspicuously, dnrx null mutants display striking defects 
in synaptic ultrastructure with the presence of detachments between pre- and postsynaptic 
membranes, abnormally long active zones, and increased number of T-bars. These 
abnormalities result in corresponding alterations in synaptic transmission with reduced 
quantal content.  Together, our results provide compelling evidence for an in vivo role of 
neurexins in regulating synapse growth, and the modulation of synaptic architecture and 
adhesive interactions between pre- and postsynaptic compartments.  
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3.2 Introduction 
 
Synapse development and function form the basis of many neuronal processes, including 
formation and functioning of neural circuits, the ability to learn, and to store and recall 
memories. Thus, elucidating the mechanisms by which synapses develop and are 
modified is a central question in neurobiology. Over the past few decades a number of 
factors have been identified that play major roles in synapse morphogenesis and synaptic 
plasticity. Among these, trans-synaptic cell adhesion and signaling molecules that 
mediate the interactions between pre- and postsynaptic membranes stand out. They are 
thought to mediate target recognition, initiate synapse formation and alignment, maintain 
the integrity of synapse, and regulate synaptic function (Scheiffele, 2003; Yamagata et 
al., 2003). In particular, neurexins and their postsynaptic binding partners the neuroligins 
are emerging as key synapse organizing molecules.   
 Neurexins were first identified as primary receptors for -latrotoxin, a neurotoxin 
that triggers massive neurotransmitter release (Ushkaryov et al., 1992). There are three 
neurexin genes in mammals, each of which has two promoters generating - and -
neurexins. Neurexins are subject to extensive alternative splicing, generating a large 
number of variants (Missler and Sudhof, 1998a; Rowen et al., 2002; Tabuchi and Sudhof, 
2002), which may mediate target recognition and synaptic specificity (Comoletti et al., 
2006; Chih et al., 2006; Rowen et al., 2002; Tabuchi and Sudhof, 2002; Graf et al., 2006; 
Boucard et al., 2005). The extracellular region of neurexins binds to neuroligins 
(Ichtchenko et al., 1995; Boucard et al., 2005) and dystroglycan (Sugita et al., 2001). 
Neuroligins are localized to postsynaptic densities (PSDs) (Song et al., 1999) and 
associated with neurotransmitter receptors by interaction with scaffolding proteins (Irie et 
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al., 1997; Meyer et al., 2004; Hirao et al., 1998). Intracelluarly, neurexins interact with 
the synaptic vesicle protein synaptotagmin (Hata et al., 1993), and PDZ domain proteins 
CASK (Hata et al., 1996) and Mints (Biederer and Sudhof, 2000), which are linked to the 
synaptic vesicle exocytosis machinery (Atasoy et al., 2007; Ho et al., 2003). Thus, the 
trans-synaptic interaction between neurexin and neuroligin may bridge the synaptic cleft 
aligning the presynaptic neurotransmitter release machinery with postsynaptic densities. 
Important findings from cell culture studies indicate that neurexins and neuroligins could 
act bidirectionally to induce pre- and postsynaptic assembly, thus controlling synapse 
formation (Scheiffele et al., 2000; Graf et al., 2004; Dean et al., 2003; Nam and Chen, 
2005; Chih et al., 2005; Prange et al., 2004; Levinson et al., 2005; Fu et al., 2003). 
Interestingly, phenotypic analyses of -neurexins triple knockout mice suggest that -
neurexins are required for neurotransmitter release but dispensable for  synapse formation 
(Missler et al., 2003; Zhang et al., 2005). Thus, despite the expanding evidence indicating 
that neurexins may act as synaptic recognition and organizer molecules in synapse 
development and function, the complexity and redundancy of neurexin genes in 
mammals pose a tremendous difficulty in understanding their function in vivo.  
 A potential strategy to resolve these issues is to use a simpler model system, such 
as the fruit fly, to investigate the in vivo function of neurexins. Our previous studies have 
identified the single Drosophila neurexin gene (dnrx) and characterized its expression 
pattern during development. DNRX is expressed in central neurons and concentrated at 
the active zone of glutamatergic neuromuscular junctions (NMJs), indicating its potential 
role in synaptic development and function, especially the formation and development of 
active zone. 
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Here we report the isolation of Drosophila neurexin (dnrx) null mutants and the 
characterization of its function during synapse development. Our results demonstrate that 
dnrx plays a critical role in synaptic growth, the cytoarchitecture of synapses, and the 
regulation of synaptic function. These studies provide a better understanding of neurexin 
function in an intact organism, and offer a strong basis for the interpretation of 
observations at mammalian central synapses. 
 
3.3 Materials and Methods 
 
Generation of dnrx Mutants 
XP d08766 (Thibault et al., 2004), a P-element inserted ~200bp upstream of dnrx, was 
used to carry out an excision screen. To increase the frequency of large deletions, the 
excision screen was carried out in mus309 background (Adams et al., 2003; McVey et al., 
2004). Briefly, XP d08766 was first recombined to mus309
N1
 and 
mus309
N1
,XPd08766/TM6 Tb recombinants were identified by single fly PCR using 
mus309
N1
- and XPd08766- specific primers. Next, mus309
N1
 XPd08766/TM6 Tb males 
were massively mated with mus309
D3 Sb ∆2-3/TM6 Tb females.  The mus309N1 
XPd08766/mus309
D3
 Sb ∆2-3 males were individually crossed with D/TM6 Tb females. 
w
- 
male progeny was selected and individually crossed with Df(3R)5C1/TM3 Sb 
Kr::GFP. Single ∆XP/ Df(3R)5C1 male flies were  subject to PCR to select imprecise 
excisions, and ∆XP/ TM3 Sb Kr::GFP were used to establish stock lines.  dnrx deletions 
were obtained by selecting imprecise excisions downstream of the P-element insertion 
site using primer pairs covering the whole dnrx locus. The following primer pairs were 
used to confirm dnrx
273
 and dnrx
241
 alleles with a common 5’primer (5’-
ACGCGTCGCGCTAAAATCCAGCCCG-3’); and separate 3’ primers (dnrx273, 5’-
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CGTATGAGTGCTTGGAGCGGAA-3’; and dnrx241, 5’-
AGCCGGTGCCGATGTCTATGACGAA-3’). 
 
Fly Stocks and Genetics 
dnrx mutant alleles dnrx
273
, dnrx
241 
and Df(3R)5C1 (a deficiency that removes dnrx) were 
balanced over TM3 Sb Kr::GFP. dnrx mutants were identified by selecting 3
rd
 instar 
larvae without GFP expression. A precise excision of XPd08766 and/or wild-type 
(Canton-S) were used as control lines. UAS-dnrx transgenic flies were generated by 
cloning the entire dnrx full-length cDNA into pUASP vector for germ line 
transformation. Gal4 lines used for DNRX overexpression and rescue experiments were 
C380, which drives Gal4 expression mainly in motoneurons (Budnik et al., 1996), and 
elav, which drives Gal4 expression in all neurons (Lin and Goodman, 1994). DNRX 
overexpression experiments were performed by crossing Gal4 homozygous females to y 
w/Y; UAS-dnrx /UAS-dnrx; +/+ and y w/Y; UAS-dnrx /UAS-dnrx; UAS-dnrx /UAS-dnrx 
males, respectively.  For dnrx cDNA rescue studies, either C380/Y; +/+; 
Df(3R)5C1/TM6 Tb or C380/Y; +/+; dnrx
273
/TM6 Tb were crossed to +/+; UAS-dnrx 
/UAS-dnrx; dnrx
273
/TM6 Tb.  
 
Larval Locomotor Assay 
The larval locomotor assay was performed as described by Connolly and Tully (1998). 
Individual larvae were placed in the center of a 145-mm diameter Petri dish, with 3% 
agar covering the bottom and a 0.5X0.5 cm square grid marked on the lid. The number of 
grid line crossings within a 30 second time window was recorded six times. 
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Immunohistochemistry, Confocal Microscopy, and Morphological Quantification 
Preparation and antibody staining for whole-mount embryos and dissected wandering 3
rd
 
instar larvae were performed as described by Bellen and Budnik (2000). Dissected larval 
NMJs were fixed in Bouin’s fixative for 15 min. The following antibodies were used: 
guinea pig anti-DNRX (1:500), rabbit anti-DPAK (1:2000, N. Harden, Simon Fraser 
University, Canada; (Harden et al., 1996), rabbit anti-NWK (1:2000, B. Ganetzky, 
University of Wisconsin, Madison; (Coyle et al., 2004), rabbit anti-Syt (1:500, H. Bellen, 
Baylor College of Medicine, Houston; (Littleton et al., 1993a); rabbit anti-GluRIII 
(1:2000, A. DiAntonio, Washington University, St. Louis; (Marrus et al., 2004); guinea 
pig anti-Dap160 (1:2000, H. Bellen, Baylor College of Medicine, Houston; (Koh et al., 
2004), monoclonal anti-discs-large (1:500), anti-BRP (1:500), anti-GluRIIA (1:50 ), and 
anti-FASII (1:100) from Developmental Studies Hybridoma Bank, University of Iowa. 
Secondary antibodies conjugated to Alexa 488, 568 and 647 (Invitrogen-Molecular 
Probes) were used at 1:400. Fluorescence conjugated anti-HRP (Jackson Immuno Labs) 
antibodies were used at 1:50.  
 Confocal images were acquired using a Bio-Rad Radiance 2000 confocal 
microscope with LaserSharp2000 software. Samples for each experiment were processed 
simultaneously, and imaged using the same settings. For Cac-GFP live imaging, larvae 
were mounted on the slides and the images were acquired from live body wall muscle 
preparations with an Improvision spinning disc confocal microscope. 
 Quantification of bouton number was performed at muscles 6/7 and muscle 4 of 
abdominal segment 3. Total boutons at NMJ6/7 and type Ib boutons at NMJ4 were 
53 
visualized by staining of body wall muscle preparations with anti-HRP. For 
quantification of axonal Syt accumulation, the length of SNb axon innervating muscles 
12/13 or ISN axon and its primary branches innervating muscle 4 in abdominal segment 3 
or 4 was measured; the number of Syt puncta along these axons was counted and further 
divided by the axon length. Statistical analyses were performed using InStat 3.00 
(Graphpad). 
 
Quantification of GluR IIA Intensity 
NMJ staining of dnrx mutant and wild-type larvae with monoclonal anti-GluRIIA and 
FITC anti-HRP was performed in the same tube. Several regions of NMJ4 from 3 
animals for each genotype were scanned by confocal microscope. Confocal stacks were 
acquired using the same settings that prevented pixel saturation with 0.25 μm steps 
through entire synaptic boutons. Images were processed using Volocity 4.1 
(Improvision). Total volumes of synaptic boutons outlined by HRP staining, and the 
fluorescence of GluRIIA staining were calculated. Total GluRIIA fluorescence divided 
by total volumes of boutons represented GluR intensity.  
 
Electron Microscopy 
Body wall muscles were prepared for transmission electron microscopy (TEM) as 
previously described (Torroja et al., 1999). Synaptic boutons were serially sectioned and 
photographed at 10,000-30,000X using a JEOL 100S TEM. For morphometric analysis, 
the cross section corresponding to the bouton midline (cross-section of largest diameter) 
was identified, the negative scanned at 60,000X, and used for quantification using Image 
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J as in Budnik et al., 1996. The number of samples used were 3 wild type controls (14 
boutons), 3 dnrx/Df (11 boutons), and 3 rescue animals (15 boutons). For analysis of 
synapse length and synapse ruffles, sections other than the midline section were also 
considered for quantification, as long as pre- and postsynaptic densities as well as the 
synaptic cleft were clearly visualized, had consistent thickness, and lacked the blurry 
appearance of membranes cut at a tangential plane. Statistical analysis was performed 
using a two-tailed Student t-test. 
 
Electrophysiology 
Electrophysiology recordings were performed as in Ashley et al., 2005.  Briefly, third 
instar larvae were dissected under cold 0.3mM Calcium HL-3 saline (Stewart et al., 1994) 
and then perfused continuously with 0.5mM Calcium HL-3 saline at 22°C.  Muscle 6 in 
segment A3 was then impaled with a 15-20 MΩ glass electrodes.  Only samples with 
resting membrane potentials between -60 mV and -63 mV were used for analysis.  Data 
was collected using an Axoclamp2A (Molecular Devices, Union City, CA), filtered at 1 
kHz, and digitized with an Instrutech (Port Washington, NY) ITC-16 computer interface 
using Pulse software (HEKA Electronik, Lambrecht/Pfalz, Germany).  Spontaneous and 
evoked events were then measured using Mini Analysis software (Synaptosoft, Decatur, 
GA.). Statistical analysis was performed using the Student's t test. 
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3.4 Results 
 
Genetic Analysis of dnrx  
To determine the role of DNRX in synaptic development and function, we generated dnrx 
null mutants. The dnrx gene is predicted to comprise 13 exons and 12 introns, spanning 
~13.4 kb. To disrupt the dnrx locus, we carried out an excision screen with a P-element 
(XPd08766) located ~200 base pairs upstream of dnrx (Fig S3.1). Our RNA interference 
study using double strand RNAs corresponding to two different regions of DNRX 
indicated that DNRX loss of function might not result in lethality (data not shown). 
Therefore, we used a single fly PCR strategy rather than screening for the lethality to 
select dnrx deletions. Two large dnrx deletion alleles, dnrx
273
 and dnrx
241
 (Fig. 3.1A), 
were isolated from the screen. The break points of the deletions were molecularly 
determined by PCR and sequence analysis. The dnrx
273
 allele had an ~8-kb deletion 
within the dnrx locus, which removed most of the coding sequence for the extracellular 
region of DNRX, from the start codon to the 4
th
 LamG domain. dnrx
241
 uncovered the 
entire dnrx gene and the upstream region of an adjacent transcription unit (Fig. 3.1A). 
Western blot analysis with the DNRX C-terminus specific antibody showed that ~200 
kDa DNRX band in wild-type was absent in dnrx
273
/Df(3R)5C1, and there was no 
detectable truncated protein in dnrx mutants (Fig. 3.1B). Immunostaining with this 
antibody also showed no detectable protein in homozygous mutant embryos (data not 
shown) and NMJs (Fig. 3.1C-C’) from both dnrx alleles, confirming that dnrx273 and 
dnrx
241
 are null alleles. In this study, the following allelic combinations were used for 
phenotypic analysis: dnrx
273
/Df(3R)5C1, dnrx
273
/dnrx
273
, and/or dnrx
273
/dnrx
241
. A 
precise excision of the P-element and a wild type strain were used as controls.  
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dnrx Mutants Display Abnormal NMJ Morphology  with Fewer Synaptic boutons 
-neurexin triple knockout mice and most double-knockout mutants die prematurely due 
to respiratory problems (Missler et al., 2003; Zhang et al., 2005). In contrast, 10% of the 
dnrx
273
/Df(3R)5C1 progeny died at pupal stages while the remaining progeny survived to 
adulthood and were fertile. This partial lethality was rescued by expressing a dnrx full-
length cDNA in neurons using the C380-Gal4 driver (Budnik et al., 1996).  
 Given that DNRX localizes to larval NMJs, we first examined whether the NMJ 
morphology altered in dnrx mutants. Compared to controls (Fig. 3.2A and 3.2E), dnrx 
mutants (Fig. 3.2B, 3.2C, 3.2F and 3.2G) had less NMJ expansion, shortened axon 
branches with fewer boutons. In addition, mutant NMJ branches often contained long 
intervening axon stretches devoid of synaptic boutons. Further quantification revealed 
that dnrx mutants had a 40-60% decrease in bouton number (Fig. 3.2I and 3.2J). The 
reduced bouton number was fully rescued by expression of the UAS-dnrx full length 
cDNA transgene in neurons (Fig. 3.2D, 3.2H, 3.2I and 3.2J).  Thus, these results suggest 
that DNRX is required for proper proliferation of synaptic boutons during larval 
development, which is necessary for coordinated matching of pre-and postsynaptic 
compartments during this period of intense growth (Griffith and Budnik, 2006). 
 In addition to synaptic regions, DNRX was localized to axons as well. Therefore, 
we also investigated whether axon guidance and pathfinding were altered in dnrx 
mutants. The specificity of axon pathfinding was examined by immunostaining with 
BP102 and FASII antibodies which stain all CNS axons and both a subset of CNS axonal 
fascicles and peripheral motor axons, respectively. No apparent defects were observed in 
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both CNS axonal pathways and muscle innervation patterns in dnrx mutants (data not 
shown). 
 
Neuronal Expression of DNRX Promotes Proliferation of Synaptic Boutons  
Studies in cell culture have indicated that neurexins and their postsynaptic binding 
partners, the neuroligins, induce synapse formation (Graf et al., 2004a; Chih et al., 2005; 
Scheiffele et al., 2000; Dean et al., 2003). Therefore, we asked whether DNRX could 
similarly induce the formation of new synaptic boutons in vivo. Expression of a full-
length dnrx transgene in wild-type background, using two different neuron-specific Gal4 
drivers, the pan-neural driver elav (Lin and Goodman, 1994) and neural driver C380, 
significantly enhanced the formation of synaptic boutons (Fig. 3.3 C, compare with 3.3A 
and 3.3B). Increasing dnrx gene dosage in all neurons by one copy resulted in over a 30% 
increase in the number of synaptic boutons, while increasing it by two copies resulted in 
more than 40% enhancement (Fig. 3.3D). A similar trend was observed by using C380-
Gal4 (Fig. 3.3D).  
Recent studies on murine central synapses suggest that postsynaptic neurexins 
affect glutamate receptor function, and may also inhibit neuroligin function via cis-
interaction with neuroligins on the postsynaptic membrane (Kattenstroth et al., 2004; 
Taniguchi et al., 2007). To explore the potential functional relevance of DNRX in the 
postsynaptic compartment at NMJs, we examined whether muscle expression of DNRX 
had any effect on synaptic growth. Compared to genetic background matched controls, 
expression of either one or two copies of a dnrx transgene in muscle cells, using the C57 
Gal4 driver (Budnik et al., 1996), did not result in any significant change in bouton 
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number (Fig.3.5E). Taken together, the DNRX loss- and gain-of-function analyses 
demonstrate that DNRX is necessary to promote the proliferation of synaptic boutons, 
and further suggest that for this function DNRX is required in the pre- but not in the 
postsynaptic compartment.  
 
DNRX Is Required for Pre- and Postsynaptic Differentiation 
We also explored whether the expression and localization of synaptic proteins were 
affected in dnrx mutants. The abundance and localization of periactive zone proteins, 
such as the cell adhesion molecule fasciclin II (FASII), the cytoskeleton adaptor protein 
nervous wreck (NWK), and the scaffolding protein for synaptic vesicle endocytic 
machinery Dap 160 (Roos and Kelly, 1998; Roos and Kelly, 1999; Koh et al., 2004; 
Marie et al., 2004), appeared unchanged in dnrx mutants (Fig. S3.2).  Several other 
synaptic proteins, including the scaffolding PDZ-protein DLG and the microtubule-
binding protein Futsch (Roos et al., 2000; Hummel et al., 2000), also appeared unaffected 
in dnrx mutants (data not shown). However, profound abnormalities in the distribution of 
synaptic vesicle and active zone proteins, as well as glutamate receptor (GluR) clusters 
were observed in dnrx mutant NMJs.  
In wild-type, synaptotagmin (Syt), a synaptic vesicle protein, is efficiently 
transported to presynaptic terminals, therefore it is seldom observed within motor axons 
(Fig. 3.4A-A’ and 3.4D; Littleton et al., 1993). In dnrx mutants, however, intense 
punctate Syt staining was often observed in motor axons (Fig. 3.4B-B’, 3.4C, and 3.4D). 
Similarly, the active zone protein, Bruchpilot (BRP) (Wagh et al., 2006; Kittel et al., 
2006), which is rarely seen in wild-type axons was also mislocalized to mutant axons 
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(Fig. 3.4C’). Notably, BRP immunoreactivity colocalized with Syt at these accumulations 
along the motor axons (Fig. 3.4C”). The abnormal accumulations of synaptic vesicle and 
active zone proteins in dnrx mutant axons suggests that DNRX is involved in the proper 
recruitment, localization, or transport of key synaptic components during presynaptic 
differentiation. 
At mammalian synapses it has been hypothesized that neurexins are required for 
the alignment of pre- and postsynaptic compartments (Graf et al., 2004; Yamagata et al., 
2003). Therefore, we next examined whether pre- and postsynaptic apposition was 
affected in dnrx mutants by double-labeling synaptic boutons with the presynaptic active 
zone marker BRP and the PSD markers Drosophila p-21 activated kinase (DPAK) (Sone 
et al., 2000) and GluRIII (Marrus et al., 2004). No gross defects in pre- and postsynaptic 
alignment were observed (Fig. 3.5A”, 3.5B”, 3.5C’’ and 3.5D”). DPAK and GluRIII 
clusters were exactly juxtaposed to active zones in dnrx mutants. However, the size of 
DPAK and GluRIII clusters was markedly enlarged in mutant boutons (Fig. 3.5B’ and 
3.5D’ [compare with 3.5A’ and 3.5C’]). Enlargement of GluRIIA clusters was also 
observed, while the GluRIIA intensity in boutons was not statistically different between 
mutant and wild-type (Fig. S3.3). Taken together, these results suggest that although the 
juxtaposition of pre- and postsynaptic components is not altered at least at the light 
microscopy, the distribution of PSD proteins is affected in dnrx mutants. 
 
Active Zones and PSDs Are Altered in dnrx Mutants 
To determine the significance of the light microscopic phenotypes described above, we 
carried out ultrastructural and functional analyses of NMJs in dnrx mutants. For the 
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ultrastructural studies, dnrx mutant and control NMJs were serially sectioned and subject 
to a morphometric analysis. dnrx mutants had striking structural abnormalities in active 
zones and PSDs of type Ib boutons. Wild type boutons are characterized by the 
presynaptic compartment containing synaptic vesicles, mitochondria and endosomes (b in 
Fig. 3.6A). At the presynaptic membrane, active zones are composed of regulatory 
electron dense structures, the T-bars (arrow in Fig. 3.6A and 3.6C) containing 
BRP/CAST (Kittel et al., 2006; Wagh et al., 2006), and the pre-synaptic densities 
(PRDs), the likely sites for synaptic vesicle fusion (Fig. 3.6C). The PRDs are exactly 
juxtaposed to PSD (between arrowheads in Fig. 3.6C and 3.6E), which contain GluRs in 
high-density clusters (Prokop and Meinertzhagen, 2006). Separating both membranes is 
the synaptic cleft which has a uniform size, and is filled with material that differs in 
electron density and structure from the rest of the bouton extracellular space (Fig. 3.6A, 
3.6C and 3.6E). 
Several features of the active zones and PSDs were altered in dnrx/Df mutants. 
PRDs and apposed PSDs were over 60% longer in the mutants compared to controls (Fig. 
3.6D and 3.6G). This is in agreement with the light microscopic studies showing that 
DPAK and GluR clusters were increased in size in dnrx mutants. In addition, the number 
of T-bars per bouton was increased by more than 2-fold (Fig. 3.6B and 3.6G). Most 
strikingly, the PRD showed signs of detachment from the PSD, a phenotype that is rarely 
seen in wild type (Fig. 3.6D, 3.6F and 3.6G). In these dnrx mutant synapses, PRDs 
showed bleb-like invaginations at several points, and at these sites the typical electron 
density of PRDs was lost (Fig. 3.6F). The material at the synaptic cleft also appeared 
altered, but no defects were observed at the corresponding sites of the PSDs (Fig. 3.6F). 
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Thus, in dnrx mutants, synapses within synaptic boutons are dramatically altered, 
showing sites of presynaptic membrane detachment, abnormally long active zones, and 
increased number of T-bars. The increase in the number of T-bars and the aberrant 
detachment of PRD were completely or almost completely rescued by expressing a dnrx 
transgene in the mutant background, respectively (Fig. 3.6G). However, the increased 
length of the active zones was only partially rescued by the transgene, suggesting that this 
phenotype might be highly sensitive to DNRX dosage. Our ultrastructural analysis of 
dnrx mutant synaptic boutons provides the first direct in vivo evidence supporting the 
model that neurexins are involved in adhesion between the pre- and the postsynaptic 
cells. 
 
dnrx Mutants Have Defects in Synaptic Transmission  which Correlate with the 
Alterations in Synapse Ultrastructure  
To assess the functional consequences of the reduced bouton number, the enlarged GluR 
clusters, the increase in the size of active zones and PSDs, and the abnormal detachments 
of PRDs, we carried out an electrophysiological analysis of NMJs (Fig. 3.7). For these 
experiments, the amplitude of spontaneous miniature excitatory potentials (mEJPs) was 
measured by intracellular recordings of muscles at low Ca
2+
 concentrations. In addition, 
the amplitude and kinetics of evoked excitatory potentials (EJPs) were measured by 
stimulating the segmental nerve containing the motor axons. Several defects were 
observed in dnrx mutants. Evoked synaptic transmission was reduced, as manifested by a 
small, but significant decrease in the amplitude of EJPs. In addition, the frequency and 
amplitude of mEJPs was dramatically increased, suggesting both a pre- and a 
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postsynaptic defect.  Overall, quantal content was reduced, indicating defective synaptic 
transmission. The defect in EJP amplitude was completely rescued by expressing a dnrx 
transgene in neurons using C380-Gal4 or ubiquitously using T80-Gal4. However, no 
rescue of the mEJP amplitude or frequency was observed, consistent with the 
ultrastructural studies, in which the size of the active zones and PSDs was only partially 
rescued by the dnrx transgene. This partial rescue is not surprising given that neuronal 
expression of a dnrx transgene in wild-type background also has deleterious effects on 
quantal content (Fig. 3.7C). It is notable that the functional abnormalities were observed 
in homozygous dnrx
273
 mutants, dnrx
273
/dnrx
241
 combinations, as well as dnrx over a 
deficiency chromosome. Thus, they are unlikely to result from any genetic background 
effects. 
 
Mutations in dnrx Have Abnormal Calcium Sensitivity without Altering the 
Distribution of Presynaptic Calcium Channels 
Studies in mammals have suggested that neurexins are involved in coupling Ca
2+
 
channels to synaptic vesicle release apparatus (Missler et al., 2003). Therefore, we next 
examined whether the Ca
2+
 sensitivity of neurotransmitter release could be altered in dnrx 
mutants. For these experiments, the amplitude of evoked responses was measured at three 
Ca
2+
 concentrations, 0.5, 0.75, and 1 mM. As previously described, there was a 
significant decrease in EJP amplitude in dnrx mutants at 0.5 mM Ca
2+
. Surprisingly, 
however, this defect was completely restored when recordings were performed at 1 mM 
Ca
2+ 
(Fig. 3.8A).  
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 The change in the slope of Ca
2+
 dependency of release could be due to either 
changes in Ca
2+
 coupling to exocytosis, or an abnormality in the distribution of 
presynaptic Ca
2+
 channels. To address this issue we examined the distribution of 
Cacophony (Cac), the presynaptic N-type Ca
2+
 channel at these synapses (Smith et al., 
1996; Littleton and Ganetzky, 2000). Ca
2+
 channels are extremely sensitive to fixation. 
Therefore, we used a GFP-tagged Cac transgene (Cac-GFP) to visualize Ca
2+
 channel in 
vivo. Previous studies have demonstrated that expression of this transgene faithfully 
replicates endogenous Cac distribution and function (Kawasaki et al., 2004; Kittel et al., 
2006). Cac-GFP transgene was expressed in neurons using elav-Gal4, and samples were 
imaged live in a spinning disk confocal microscope. There were no statistically 
significant differences either in the size or intensity of Cac-GFP clusters between controls 
and dnrx mutants (Fig. 3.8B, 3.8B’, 3.8C and 3.8 C’), indicating that the defect in Ca2+ 
sensitivity is most likely the result of changes in coupling rather than Ca
2+
 channel 
distribution. 
 
dnrx Mutants Exhibit Decreased Locomotor Activity  
 
dnrx mutants exhibited severely impaired behavior in larval stages, being uncoordinated 
and sluggish. Locomotor activity was reduced in all dnrx mutants, including the two dnrx 
alleles over deficiency and in allelic combinations. For the dnrx
273
/Df(3R)5C1 line, this 
phenotype was quantified in a larval locomotor assay. In this assay, the number of grids 
on a horizontal agar surface entered by individual 3
rd
-instar wandering larvae within a 30 
sec time window over a test period of 180 sec was counted. While control animals passed 
about 5 grids on average, dnrx
273
/Df(3R)5C1 mutants entered less than 2 grids (Fig. 3.9). 
64 
This phenotype was completely rescued by expressing DNRX in neurons using the C380-
Gal4 driver (Fig. 3.9). Thus, decreased locomotor activity is due to dnrx loss-of-function 
in neurons.  
 
3.5 Discussion 
Although cell adhesion molecules have long been postulated and in several cases, shown 
to be major participants in synapse development and plasticity, the impact of their 
function and the molecular mechanisms that they activate remain a puzzle. Particularly 
intriguing is the function of neurexins, which may provide clues to our understanding of 
synapse organization. We have isolated null mutants in the single Drosophila dnrx gene. 
We show that dnrx mutants have striking abnormalities in synapse development and 
function. A recent study reported that Drosophila neurexin is required for synapse 
formation in the adult CNS (Zeng et al., 2007). In the current study, we not only 
demonstrate a primary role of DNRX in regulating synapse formation during NMJ 
expansion, but also reveal the crucial role of DNRX in the proper development of active 
zones and regulating synaptic function in an intact organism, thus providing novel 
insights into understanding the function of neurexins in vivo.  
 
Function of DNRX during Synapse Development 
Our studies provide compelling evidence that DNRX plays a prime role during the 
expansion of the NMJ and in particular, in defining the cytoarchitecture of the active 
zones within synaptic boutons. First, in dnrx mutants synaptic bouton proliferation is 
severely disrupted, and therefore NMJ expansion is significantly stunted. Second, DNRX 
gain of function promotes the formation of new boutons in a gene dosage-dependent 
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manner. Third, the ultrastructural analyses show that PRDs are not apposed normally to 
PSDs displaying signs of abnormal adhesion to the PSD, although every PRD is exactly 
juxtaposed to the PSD. Fourth, in dnrx mutants critical components of the presynaptic 
compartment, such as synaptic vesicle proteins and active zone components are 
ectopically localized within axons. Fifth, the distribution of GluRs at the PSD is 
abnormally large, although this phenotype may arise as a consequence of the presynaptic 
defects observed in dnrx mutants (discussed below).  
 The great majority of abnormal phenotypes in dnrx mutants could be completely 
rescued by expressing a wild type dnrx transgene in neurons; although in some instances 
the rescue was partial. However, even in the later case expressing dnrx in both muscles 
and neurons did not further improve the residual abnormalities, suggesting that dnrx 
functions primarily if not exclusively in the presynaptic compartment. This is consistent 
with our findings from in situ hybridization and immunostaining studies, which showed 
that DNRX mostly localizes to the presynaptic terminals. 
 The partial rescue of some of the phenotypes, such as the defects in mEJPs and 
the morphology of active zones, might be due to the high sensitivity of these processes to 
the right levels and correct temporal expression of dnrx, which is not completely 
mimicked by the UAS/Gal4 system. This view is supported by the observation that 
overexpression of  dnrx in a wild type background also decreased quantal content, 
suggesting that increased dnrx dosage may have detrimental effects on synapse structure 
and/or function. However, the data strongly support that the abnormal phenotypes arise 
from the lack of dnrx. First, all our experiments were carried out in mutants over a 
deficiency chromosome in an independent genetic background. Second, a precise 
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excision of the P-element did not show any of the mutant phenotypes. Together these 
data establish a specific role for DNRX in proper synaptic development.  
 
Role of DNRX in Active Zone Morphogenesis 
One of our important findings is that dnrx mutants displayed defective active zones with 
larger PRD, and especially containing regions of detachment from the PSD. These 
detachment sites implicate DNRX as a mediator of cell adhesion between the pre-and the 
postsynaptic cell, in accordance with previous suggestions in mammalian neurons 
(Scheiffele et al., 2000; Graf et al., 2004; Dean et al., 2003). While a complete 
detachment of active zones is not observed, dnrx mutants have a significant decrease in 
the number of boutons. This raises the possibility that the phenotypes we observe are 
from those boutons that are maintained, and that a more drastic consequence is a failure 
to form synaptic boutons. Nevertheless, the lack of complete detachment of active zones 
in dnrx null mutants suggests that DNRX, although an important synapse organization 
molecule, is not sufficient for trans-synaptic cell adhesion.  
Another notable phenotype in dnrx mutants was the presence of enlarged PRDs 
and increased number of T-bars. A major feature of Drosophila larval NMJ is its ability 
to compensate for decreased postsynaptic responses by upregulating neurotransmitter 
release. For instance, a decrease in the number of postsynaptic GluRs results in an 
increase in neurotransmitter release, thus maintaining the amplitude of evoked responses 
(Petersen et al., 1997). It is plausible that the enlarged PRDs and increase in number of T-
bars in dnrx mutants are a compensatory mechanism to adjust for defective presynaptic 
cell adhesion and/or reduced neurotransmitter release (Murthy et al., 2001; Stewart et al., 
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1996). In support of this notion, in dnrx mutants there was a 50% decrease in synaptic 
bouton number, but this was accompanied by a 2-fold increase in the number of T-bars, 
such that the total number of T-bars/NMJ remained constant, despite the changes in 
bouton number.  Similarly, defective presynaptic cell adhesion and/or reduced 
neurotransmitter release could lead to an increase in GluR accumulation (O'Brien et al., 
1998). In our studies we found that the length of the PSD was enlarged in dnrx mutants as 
well as the distribution of GluR clusters. 
 
Functional Consequences of Altering DNRX Function 
The above structural abnormalities were accompanied by corresponding functional 
deficits. In dnrx mutants the frequency of mEJPs was strikingly increased. Further, 
although the T-bars were rescued by expression of a dnrx transgene, the length of the 
PRDs was not, and a similar lack of rescue was observed for mEJP frequency. Thus, 
there appears to be a notable correlation between the size of the PRD and mEJP 
frequency perhaps due to increased probability of synaptic vesicle release with increased 
synapse size. In addition, we also observed a substantial increase in mEJP amplitude. 
Two factors may contribute to this change. First, the distribution of GluR clusters was 
enlarged while the GluR intensity remains unchanged, suggesting that more GluRs were 
accumulated at mutant synapses. An additional contributing factor is that mEJP 
frequency was increased, and we observed instances of summation. 
Overall, despite the increase in PRD size and the maintenance of overall T-bar 
number, evoked events had a decrease in amplitude, and quantal content. Recent studies 
have suggested that a major constituent of the T-bars is BRP/CAST (Kittel et al., 2006; 
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Wagh et al., 2006). In brp mutants T-bars fail to form, but PRDs appear unaltered. 
Further, although EJP amplitude is decreased, mEJP amplitude and frequency are normal. 
This has led to the model that T-bars per se are not required for synaptic transmission, 
but that they regulate the efficiency of transmission. In dnrx mutants, PRDs are 
disproportionately large, which could result in asynchronous release, leading to an EJP 
with decreased amplitude. It is also possible that the presynaptic membrane detachments 
observed in dnrx mutants could contribute to the functional impairment of 
neurotransmitter release. 
A recent study demonstrated that in dnrx mutant larvae associative learning is 
impaired in an olfactory choice paradigm (Zeng et al., 2007). However, in this study 
larval locomotion was not assessed. Our study showing that locomotor behavior is 
impaired in dnrx mutants raises the possibility that the poor performance of mutant larvae 
in the conditioning assay might also result from the locomotor abnormalities. Zeng et al 
also reported that the number of T-bars in the calyx of the mushroom bodies, the learning 
centers of the fly, was reduced in adult flies. In contrast, we found a significant increase 
in the number of T-bar per bouton, and since dnrx mutants have fewer boutons, this 
translated in the maintenance of T-bar number per NMJ. The differing results might be 
due to different mechanisms regulating T-bar formation in the two tissues.  
 
DNRX Function in Relation to Mammals 
The presence of a neurexin in Drosophila strengthened the view that neurexins are highly 
conserved across species (Tabuchi and Sudhof, 2002). The synaptic DNRX expression 
pattern and its function show remarkable parallels with mammalian neurexins. Moreover, 
69 
the proteins that have been shown to interact with mammalian neurexins also have 
homologs in Drosophila, which further supports the idea that the function of neurexins 
and underlying signaling mechanism are evolutionarily conserved. Among these, 
Drosophila neuroligin and/or dystroglycan (Dg) (Deng et al., 2003) might be potential 
DNRX ligands. Drosophila neuroligin transcription exhibits almost an identical temporal 
and spatial expression pattern as dnrx during embryonic stages (Li, J. et al., unpublished 
data). dg is highly expressed in the somatic musculature of embryos (BDGP gene 
expression report).  dg mutants are embryonic lethal, and perturbation of Dg function by 
RNAi as well as genetic interaction studies suggest an involvement of Dg in muscle 
maintenance and axonal pathfinding in adult flies (Shcherbata et al., 2007). Future studies 
on the identification and characterization of DNRX binding partners in Drosophila 
should provide additional insights into the mechanisms by which neurexins function in 
synapse development and function. 
 Extensive cell culture studies of neurexins and neuroligins and functional studies 
using -neurexin knockout mice have established a central role for neurexins as synaptic 
adhesive and organizing molecules. Our studies on DNRX provide novel evidence in an 
intact organism that neurexin is required for important aspects of synapse development 
and function. Our DNRX gain-of-function analysis reveals overexpression of DNRX is 
sufficient to promote the formation of synaptic boutons in vivo, in agreement with the 
findings from cell culture studies suggesting that neurexin-neuroligin trans-synaptic 
complexes can induce pre- and post-synaptic differentiation and synapse formation (Graf 
et al., 2004; Scheiffele et al., 2000; Dean et al., 2003; Chih et al., 2005). Moreover, the 
accumulations of synaptic vesicle and active zone proteins along axons of dnrx null 
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mutants further support the notion that neurexins may recruit or organize synaptic 
proteins or organelles during presynaptic differentiation. Phenotypic analyses of -
neurexin knockout mice demonstrated that -neurexin is essential for synaptic 
transmission in a process that depends on presynaptic voltage-dependent Ca
2+
 channels 
(Missler et al., 2003; Zhang et al., 2005). However, triple knockout mice have normal 
surface expression of Ca
2+ 
channels. These findings have led to the hypothesis that 
neurexins regulate the coupling between Ca
2+
 channels and the neurotransmitter release 
machinery. Similarly, in dnrx null mutants we found that the Ca
2+ 
sensitivity of evoked 
responses was abnormal, but the distribution or levels of presynaptic Ca
2+
 channel Cac 
was unchanged, consistent with the above hypothesis. Notably, Syt I, a synaptic vesicle 
protein that binds Ca
2+ 
and has been proposed to function as a Ca
2+ 
sensor (Geppert et al., 
1994; Yoshihara and Littleton, 2002; Brose et al., 1992) during synaptic vesicle 
exocytosis , was partly mislocalized to axons in dnrx mutants. Furthermore, the structure 
of active zones was impaired in these mutants. Therefore, the organization of active zone 
proteins including the assembly of neurotransmitter release machinery might be affected 
in dnrx mutants.  
 
In conclusion, our studies in Drosophila demonstrate that DNRX is required for 
both synapse development and function, and in particular for proper formation of active 
zones. Our studies provide compelling evidence for an in vivo role of neurexins in the 
modulation of synaptic architecture and adhesive interactions between pre- and 
postsynaptic compartments. 
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Figure 3.1 Generation of dnrx Mutants 
(A) Genomic structure of dnrx with the intron-exon organization. Exons are indicated by 
black boxes and introns by open boxes. The adjacent genes and directions of their 
transcription are denoted by gray boxes and arrows, respectively.  The P element 
XPd08766 is inserted ~200 bp upstream of dnrx.  dnrx alleles (dnrx
273
 and dnrx
241
) with 
their deleted regions indicated by hatched boxes were generated by imprecise excisions 
of XPd08766. The primers used for PCR and sequencing to define the break points of 
deletions are indicated by black arrows.   
(B) Western blot of adult head membrane extracts of wild-type and dnrx
273
/Df flies 
probed with anti-DNRX (upper panel) and re-probed with anti-NRX IV (lower panel). 
The ~200 kDa DNRX band is absent in dnrx
273
/Df mutants. NRX IV is the loading 
control. 
(C-C’) Double-staining of dnrx273/ Df mutant NMJ with anti-BRP (red) and anti-DNRX 
(green) showing  that DNRX immunoreactivity is absent from synaptic boutons (C’) 
where only BRP immunoreactivity is detected (C). Scale bar, 15 μm. 
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Figure 3.2 DNRX Loss-of-function Leads to Reduced Synaptic Bouton Number at 
Larval NMJs 
(A-H) NMJ morphology at muscle 6/7(A-D) and muscle 4 (E-H) of larval abdominal 
segment 3 labeled with anti-HRP. Compared to wild-type (A and E), dnrx null mutants 
dnrx
273/
dnrx
273
 (B and F) and dnrx
273
/Df (C and G) have less NMJ expansion, shorter 
axonal branches, and fewer boutons. A rescue line with neuronal expression of UAS-dnrx 
cDNA in dnrx
273/
dnrx
273 
background appears to restore NMJ morphology (D and H). 
Scale bars, 15 μm. 
(I and J) Quantification of total bouton number at NMJ 6/7 (I) and type Ib bouton number 
at NMJ4 (J).  Both quantifications show that dnrx mutants dnrx
273/
dnrx
273
, dnrx
273
/dnrx
241 
and dnrx
273/
Df3R(5C1) have a significant decrease in average bouton number when 
compared to wild-type and precise excision homozygotes. The reduced bouton number is 
completely rescued by restoring DNRX expression in neurons (rescue: C380/+; UAS-
dnrx/+; dnrx
273
/dnrx
273
). ***P<0.001, data are mean±SEM.  
 
73 
74 
Figure 3.3 Neuronal but Not Muscular Overexpression of DNRX Promotes 
Proliferation of Synaptic Boutons 
(A-C) NMJ morphology at muscle 6/7 in animals with DNRX overexpression in neurons. 
Compared with control animals (A) that lack dnrx transgene (C380-Gal4) or (B) that 
overexpress an unrelated gene (C380-Gal4; UAS-lacZ) in neurons, (C) animals with 
DNRX overexpression in neurons (C380-Gal4; UAS-dnrx) have more branching and 
boutons. Scale bar, 15 μm. 
(D) Quantification of bouton number shows that animals overexpressing either one-
(Gal4; UAS-dnrx) or two-copy (Gal4; UAS-dnrx; UAS-dnrx) dnrx transgene driven by 
either neuron (C-380) or panneuron (elav) Gal4 divers have a significant increase in 
average bouton number, when compared to control animals that lack a dnrx transgene 
(Gal4) or that express an unrelated gene (Gal4; UAS-LacZ). ***P<0.001, Data are 
mean±SEM. 
(E) Quantification of bouton number shows that there is no significant change in average 
bouton number between animals that express dnrx transgene in muscles driven by C57 
Gal4 and control animals. Data are mean±SEM. 
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Figure 3.4 Synaptic Component Proteins Are Mislocalized to Axons in dnrx Mutants    
(A-B’) NMJ 4 stained with anti-Syt (red) and anti-HRP (green) in wild type (A and A’) 
and dnrx mutants (B and B’). dnrx mutants display accumulation of Syt staining puncta 
in motor axons (B and B’, arrowheads). 
(C-C”) NMJ 4 of dnrx mutant stained with anti-Syt (green), anti-BRP(red) and anti-HRP 
(blue), showing co-localization of Syt and BRP staining (arrows) in accumulated puncta 
along the axon. Scale bar, 15 μm (B’ and C”). 
(D) Quantification of Syt-puncta observed in axons innervating muscle 4 and muscle 
12/13 shows that dnrx mutants have significantly increased Syt accumulation per unit 
axon length. n>76; ***P<0.001. Data are mean±SEM.  
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Figure 3.5 Distribution of PSD Proteins Is Enlarged in dnrx Mutant Boutons 
(A-B’’) Synaptic boutons of wild-type (A-A’’) and dnrx mutant (B-B’’) double-stained 
for BRP (red) and DPAK (green), which labels the presynaptic active zone and PSD, 
respectively. The pre- and postsynaptic alignment appears grossly unaffected in dnrx 
mutants. However, the distribution of DPAK within synaptic boutons is increased in dnrx 
mutant. 
(C-D’’) Synaptic boutons of wild-type (C-C’’) and dnrx mutants (D-D’’) double-stained 
for BRP (green) and GluRIII (red).  The apposition of GluRIII and BRP staining appears 
normal in dnrx mutants. However, the distribution of GluRIII cluster is enlarged in dnrx 
mutant. Scale bar: 5 μm (D”). 
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Figure 3.6 Ultrastructural Analysis of Type I Synaptic Bouton in dnrx Mutants.  
(A-F) TEM micrographs of (A, C, E) wild type, and (B, D, F) dnrx
273
/Df mutants.  
(A, B) are low magnification view of synaptic bouton midlines (b), showing the 
presynaptic active zones (arrows) and post synaptic SSR. Note that in dnrx
273
/Df mutants 
the number of active zones is increased.  
(C, D) Higher magnification view of the PSD (between arrowheads) and its juxtaposed 
PRD containing a T-bar. In dnrx
273
/Df mutants both PSDs and PRDs are much longer 
than wild type. In addition, the presynaptic membrane shows signs of detachment from 
the PSD (curved arrows).  
(E, F) High magnification view of a region of the PRD and apposed PSD. While in wild 
type the synaptic cleft between the PSD and PRD has a constant size, in dnrx
273
/Df 
mutants this size is variable, due to the presence of detachments of the presynaptic 
membrane (curved arrows). Also note that at sites of detachments the PRD no longer 
displays its typical electron density.  
(G) Morphometric analysis of synaptic boutons, showing bouton midline area, number of 
T-bars, synapse length, number of ruffles/synapse, and vesicle density. Numbers in 
parenthesis below genotypes correspond to the number of samples. ***P<0.001; 
**P<0.01; and *P<0.05. Data are mean±SEM.  
Scale bars, 1 µm (A and B); 0.2 µm (C and D); 0.1 µm (E and F). 
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Figure 3.7 Electrophysiological Analysis of NMJs.  
(A) Representative traces of mEJPs in the genotypes indicated. Note that both the 
frequency and amplitude of mEJPs is enhanced in dnrx/Df mutants.  
(B) Representative traces of evoked responses, showing a decrease in peak amplitude in 
dnrx/Df mutants. Calibration scale:  3 mV and 230 msec (A); 6 mV and 10 msec (B).  
(C) Quantification of EJP and mEJP amplitude, mEJP frequency, and quantal content 
(EJP/mEJP amplitude). ***P<0.001; **P<0.01; and *P<0.05. Data are mean±SEM. 
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Figure 3.8 Mutations in dnrx Have Abnormal Calcium Sensitivity without Altering 
the Distribution of Presynaptic Calcium Channels 
(A) EJP amplitude as a function of external Ca
2+
 concentration in wild type and dnrx 
mutants. 
(B-C’) Confocal images of NMJ 6/7 in preparations expressing Cac-GFP in neurons and 
imaged live in wild type (B and B’), and dnrx mutants (C and C’). No significant changes 
in the intensity of the signal between the two genotypes were found (WT: 100±1.4, n=9; 
dnrx273/Df: 97.9±1.2, n=6).  Scale bars, 17 µm (B and C); 4 µm (B’and C’). 
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Figure 3.9 dnrx Mutants Display Decreased Locomotor Activity. 
Quantification of locomotor activity of wall-wandering 3rd instar larvae within a 30 sec 
time window over a test period of 180 sec. The precise excision/Df performed as well as 
wild-type, whereas dnrx
273
/Df displayed significantly reduced locomotor activity 
(***P<0.0001). This phenotype was completely rescued with neuronal expression of a 
dnrx full-length cDNA (C380/+; UAS-dnrx/+; dnrx
273
/Df). For all genotypes, n=20. Data 
are mean±SEM. 
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Supplemental Figures 
Figure S3.1 Genetic Excision Screen to Generate dnrx Deletion Mutants 
(A) The genetic scheme of P-element (XP d08766) excision screen mediated by ∆2-3 
transposase in mus309 background (see Materials and Methods). 
(B) Location of XP d08766 in dnrx region and a PCR strategy to isolate dnrx deletion 
mutants. Primers for PCR screening of deletions are indicated by arrows. 
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Figure S3.2 Distribution of Active and Periactive Zone Proteins in dnrx Mutants 
Synaptic boutons of wild-type (A-A’’, C-C’’ and E-E’’) and dnrx mutants (B-B’’, D-D’’ 
and F-F’’) double-stained for active zone (DPAK and BRP, red) and periactive zone 
markers (FASII, NWK and Dap 160, green). Mutant boutons have increased distribution 
of DPAK (B). The cell adhesion molecule FASII, the cytoskeleton adaptor protein NWK 
and the endocytotic protein Dap 160 surrounding the active zone proteins have a similar 
distribution in dnrx mutants (B’-B’’, D’-D’’, and F’-F’’) as in the wild-type (A’-A’’, C’-
C’’ and E’-E’’). Scale bar: 5µm 
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Figure S3.3 Distribution and Intensity of Postsynaptic GluRIIA in dnrx Mutants. 
NMJ staining for GluRIIA in wild-type (A) and dnrx mutants (B). Note that the 
distribution of GluRIIA clusters is increased in dnrx mutants.  
(C) Quantification of GluRIIA fluorescence intensity in synaptic boutons. HRP is the 
internal control. Relative intensity is expressed as percent of wild type level. No 
significant difference is observed between mutant and wild-type boutons. Data are 
mean±SEM. Scale bar: 5 μm 
 
  
  
 
 
CHAPTER FOUR 
CONCLUSIONS 
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4.1 Summary of Findings 
The studies presented here characterized the single Drosophila neurexin gene dnrx and 
identified its in vivo function in synapse development and function.   
 We found that during Drosophila development, dnrx expression starts before the 
differentiation of presynaptic terminals, and is highly enriched in CNS neurons. DNRX 
localizes to CNS synaptic regions, axons, and glutamatergic NMJs.  At larval NMJ, 
DNRX is concentrated at active zones, but also extends into periactive zones within 
synaptic boutons.  
dnrx null mutants are viable, but display reduced locomotor behavior. Using 
Drosophila NMJs, we demonstrate that dnrx loss of function prevents the normal 
proliferation of synaptic boutons, while dnrx gain of function in neurons has the opposite 
effect, suggesting an essential role of DNRX in control of synaptic growth. In dnrx 
mutants, synaptic vesicle and active zone component markers are mislocalized along 
axons, suggesting that DNRX is required for the proper recruitment and localization of 
key synaptic components during presynaptic differentiation. Conspicuously, dnrx null 
mutants display striking defects in synaptic ultrastructure with the presence of 
detachments between pre- and postsynaptic membranes, abnormally long active zones, 
and increased number of T-bars. These abnormalities result in corresponding alterations 
in synaptic transmission with reduced neurotransmitter release.   
Our results provide compelling evidence for an in vivo role of DNRX in synaptic 
growth, the proper formation and organization of active zones, the adhesive interactions 
between pre- and postsynaptic compartments, and regulation of synaptic transmission. 
These findings provide novel insights into understanding the function of neurexins in 
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vivo, and offer a strong basis for the interpretation of observations at mammalian central 
synapses.  
 
4.2 Future Directions 
Dissecting the underlying mechanisms by which DNRX functions at synapses 
Our findings suggest that DNRX have multiple distinct but interrelated roles during 
synapse development, from recruiting synaptic building block proteins and promoting 
synapse growth to mediating the physical link across synaptic cleft and modulating 
synaptic transmission.  The particular aspects of DNRX function might be specified by 
particular domains of DNRX, their specific interacting proteins, and thereby specific 
signaling pathways.  
 We found that the proteins that have been shown to interact with vertebrate 
neurexins have homologs in Drosophila, further supporting the idea that the function of 
neurexins and underlying signaling mechanisms might be evolutionarily conserved across 
species. Our initial studies on the expression pattern of these Drosophila homologs and 
protein-protein interactions have identified the potential binding partners of DNRX (Li, J. 
et al., unpublished data). Among these, Drosophila neuroligin and/or dystroglycan (Dg) 
(Deng et al., 2003) might be potential DNRX ligands. In addition, Camguk, the 
Drosophila homolog of PDZ scaffolding protein CASK (Martin and Ollo, 1996), might 
be an intracellular binding partner of DNRX.  
 Drosophila neuroligin mRNA appears at embryonic stage 14 and almost 
exclusively in CNS neurons with no detectable expression in muscles, which is almost 
identical to dnrx expression pattern in embryos (Li, J. et al., unpublished data). Dg is 
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highly expressed in the somatic musculature of embryos (BDGP gene expression report), 
and present at NMJ (Li, J. et al., unpublished data). Dg mutants are embryonic lethal 
(Deng et al., 2003), and perturbation of Dg function by RNAi and genetic interaction 
studies suggest a role of Dg in muscle maintenance and axon pathfinding (Shcherbata et 
al., 2007). Future studies on characterization of Drosophila neuroligin and Dg, their 
functions at NMJ and interactions with DNRX are required to understand the functional 
significance of neurexin-mediated transynaptic adhesion during synapse development. 
 Camguk is expressed in neurons (Martin and Ollo, 1996; Lopes et al., 2001) and 
localized to type I NMJs (Li, J. et al., unpublished data). Caki, a null mutant of Camguk, 
is viable but exhibits reduced locomotor behavior, and defects in learning and memory 
formation in adult flies (Martin and Ollo, 1996; Lu et al., 2003). The major phenotype of 
CASK knockout mice and caki mutant at synapses are similar, including an increase in 
the frequency of glutamatergic spontaneous neurotransmitter release, suggesting their 
primary role in regulation of synaptic function (Atasoy et al., 2007; Zordan et al., 2005). 
The phenotype of caki at larval NMJ has not been reported. Our initial characterization 
revealed that the NMJ morphology appeared normal and there was no defect in synaptic 
growth in caki mutant. However, similar to the dnrx mutant, synaptic component proteins 
were accumulated in the motor axons of caki mutant (Li, J. et al., unpublished data). 
Thus, the preliminary data indicate that there might be unidentified DNRX intracellular 
binding partner(s) that mediate the signaling pathway controlling synaptic growth. 
Further studies are needed to confirm the association of Camguk with DNRX in vivo, 
their functional relevance and signaling complexes they are involved in. Identification of 
additional DNRX interacting proteins is also required to dissect the intracellular signaling 
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pathways that mediate synaptic assembly and growth.  In addition, an in vivo structure 
and function approach should also provide insights into the mechanisms underlying the 
function of DNRX. For instance, if a particular phenotype of dnrx mutant is selectively 
rescued by a dnrx transgene containing a particular domain but not rescued by the 
transgene lacking this domain; it would suggest that a particular aspect of DNRX 
function is specified by this domain and associated signal complexes. 
 Together, future studies on DNRX structure-function relationship, identification 
and characterization of DNRX binding proteins, their functional relevance to DNRX 
should shed light on the cellular and molecular mechanisms by which neurexins function 
in synapse development and function.   
 
Identifying the role of DNRX in the molecular mechanism of retrograde synaptic 
signaling  
Synaptic homeostasis requires two-way communication between pre- and postsynaptic 
cells to adjust coordinated synaptic performance. For example, during Drosophila larval 
development, the number of synaptic boutons and number of active zones per bouton 
increase substantially as the larval muscle expands dramatically in size to achieve proper 
muscle depolarization (Keshishian and Kim, 2004). Recent studies have suggested that 
retrograde signaling derived from postsynaptic cells is essential for synaptic homeostasis 
(Haghighi et al., 2003; Sanyal et al., 2004). The retrograde control of synaptic 
homeostasis is more evident when presynaptic terminals respond to experimental 
manipulations, e.g. inhibition of postsynaptic transmitter receptors results in a 
compensatory enhancement of transmitter release (Haghighi et al., 2003).  
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 A variety of diffusible and membrane-bound factors have been proposed to 
convey the retrograde signaling across synaptic cleft. Among these, TGF/BMP 
signaling pathway has been demonstrated to be involved in the retrograde control of 
synaptic homeostasis at Drosophila NMJ during development and experimental 
manipulations (Haghighi et al., 2003; Marques and Zhang, 2006). Strikingly, the 
phenotypes in dnrx mutants resemble those arising by mutations in BMP signaling 
pathway. In this pathway, the BMP homolog Glass bottom boat (Gbb) is released from 
muscles, and activate its presynaptic receptors on motor neurons including type II 
receptor Wishful thinking (Wit), type I receptors Thick veins (Tkv) or Saxophone (Sax),  
leading to the phosphorylation of receptor-regulated Smad (R-Smad). Phosphorylated R-
Smad forms a complex with common Smad (Co-Smad) and translocates into the motor 
neuron nucleus, where it acts as a transcriptional regulator to direct the expression of 
TGF/BMP responsive genes (McCabe et al., 2003). Loss-of-function mutations in the 
components of BMP signaling pathway such as Wit and Gbb result in a decrease in 
synaptic bouton number, a reduction in neurotransmitter release and alterations in 
synaptic ultrastructure that are remarkably similar to the defects observed in dnrx mutants 
(Marques et al., 2002; McCabe et al., 2003; Aberle et al., 2002). This suggests a link 
between dnrx and TGF/BMP signaling pathway. Indeed, target-derived BMP4 has been 
shown to induce upregulation of neurexin expression in mouse sympathetic neurons 
(Patzke et al., 2001). Therefore, it is likely that neurexins might be one of target genes 
regulated by TGF/BMP retrograde signaling to induce coordinated presynaptic response 
such as the enhancement of synaptic growth and regulation of neurotransmitter release.  
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 In addition to acting as a presynaptic effecter of TGF/BMP-dependent retrograde 
signaling, it is also plausible that neurexins might be a direct presynaptic mediator of 
membrane-bound retrograde signaling, given its trans-synaptic location with neuroligins. 
A recent study demonstrated that postsynaptic PSD-95-neuroligin complex modulates 
presynaptic neurotransmitter release probability in a retrograde way by increasing 
sensitivity to extracellular Ca
2+
. And this retrograde effect might be mediated by 
presynaptic neurexins (Futai et al., 2007).  
 Taken together, several lines of emerging evidence indicate a role of neurexins in 
retrograde synaptic signaling. However, the key evidence for this role is still lacking. 
Future studies to test whether the retrograde effects trigged by genomic and /or 
pharmacological manipulations will be abolished in dnrx mutant background, and 
whether DNRX is regulated by TGF/BMP signaling pathway should provide the direct 
evidence identifying the role of neurexins in retrograde signaling and synaptic 
homeostasis. 
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